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ABSTRACT
The study of antibody responses in prominent aquaculture species such as the rainbow 
trout, Oncorhynchiis mykiss. can facilitate vaccine development and contribute to 
producing useful paradigms of adaptive immunity in lower vertebrates. Thus, it is 
essential to identify genes responsible for antibody responses. In the mouse model, 
hvbridoma technology allows for the association of monoclonal antibodies possessing 
various affinities for antigen with specific VH sequences, gene family utilization, and 
other molecular events (i.e. somatic hypermutation) that occur during the specific 
immune response. The absence of a comparable hybridoma technology in piscine 
systems has limited similar studies of fish immunogenetics to date. Molecular and 
serological experiments were performed in an attempt to obtain information regarding 
somatic mutation and VH gene utilization for trout antibodies without reliance on 
hybridoma technology. PCR primers recognizing consensus sequences of FRL and FR3 
were used to amplify antibody VH sequences from panned, antigen-specific B cells. To 
follow the development of the expressed VH repertoire, lymphocytes were obtained at 
weeks 0, 5, 10, and 20 post primary immunization with trinitrophenylated-keyhole limpet 
hemocyanin (TNP-KLH) or infectious hematopoietic necrosis virus (IHNV). 
Lymphocytes were also collectedIO weeks post secondary immunization (week 35). 
These studies were conducted in parallel with serological analyses of plasma antibodies 
obtained from the same sample in order to correlate molecular data with serological data 
from individual trout. Antigen-specific lymphocytes were processed to isolate RNA 
templates to produce cDNA which was cloned and sequenced. This sequence analysis 
allowed us to report, for the first time, the temporal accumulation of potential somatic 
variants that correlate to the development of new, high affinity antibody subpopulations 
during the immune response, some with the emergence of new antibody heavy chain 
isoelectropherotypes as identified by 2D-IEF/SDS-PAGE. Southern analysis and gene 
titration using various antigen-specific cDNA probes allowed us to correlate trout 
antibodies possessing various affinities for antigen with specific VH sequence and gene 
family utilization. Thus, trout Ig VH gene family utilization appears to follow the mouse 
model of differential use for specific immune response. These results reveal a capability 
for fine-tuning the piscine immune response previously not recognized. Furthermore, 
the identification of specific VH gene families used in generating antibodies to specific 
antigens will permit exhaustive germline sequence analysis in the future which is 
requisite for the absolute confirmation of these mutational processes.
x
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INTRODUCTION
Somatic mutation is the process whereby antibody genes are mutated within 
mature lymphocytes. These mutations are capable of creating new binding site variants 
from which higher affinity antibody producing cells may be preferentially expanded via 
antigen-driven selection. In essence, this is the primary process by which mammalian 
antibody, particularly IgG, IgA and IgE, responses develop their enhanced specificity 
post immunization. However, our mechanistic understanding of antigen selection and 
somatic mutation has yet to be fully developed, particularly in lower vertebrates. 
Somatic mutation has been observed in the African clawed frog Xenopus laevis (Wilson 
et al. 1992) and the homed shark Heterodontus francisci (Hinds-Frey et al. 1993). 
however, such observed molecular changes have yet to be associated with either a 
specific immune response or a corresponding increase in affinity. In these studies, 
variation from germline sequences were identified in non-immunized animals, thus, no 
association with antigen-driven selection could be made. While the presence of 
somatically mutated VH genes could be taken as corroborative evidence of a past, 
antigen-specific response, it is not conclusive. Such substantiation would require the 
observation of the emergence of somatic variants during a response to specific antigenic 
challenge.
Examination of the antigen-specific response in rainbow trout (Oncorhynchus
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
mykiss) against two distinct protein antigens, the model antigen trinitrophenvlated- 
kevhole limpet hemocyanin (TNP-KLH) from which an epitope-specific (TNP) specific 
response can be studied and the economically relevant viral antigen (infectious 
hematopoietic necrosis virus glycoprotein, IHNV gp) provides insight into the molecular 
processes occurring during the maturation of the specific antibody response in a teleost 
fish. Ultimately, this study may provide molecular evidence that contributes to the 
development of effective anti-viral vaccine strategies in teleost fish by identifying the 
conditions requisite for optimal affinity maturation of anti-viral antibodies. Also of 
potential importance is the role of somatic mutation in development of an anti-viral 
response in fish since many pathogens in aquaculture are viruses.
Antibody structure
Antibody (Ab) molecules, which are also termed immunoglobulin (Ig) molecules, 
are found in ail jawed vertebrates. The structure of the Ig monomer consists of two 
heavy (H) chains and two light (L) chains, with each protein chain comprised of two 
principal regions: the N-terminal variable region (V) and the C-terminal constant region 
(C). Although separate genes encode the variable and constant regions, the two genes are 
never independently expressed and together they encode a single polypeptide product 
(Dryer and Bennett 1965).
3
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In teleost fish, antibodies appear primarily as tetrameric molecules (termed IgM), 
composed of four monomeric subunits with the molecular weight of the monomer H 
chains approximately 72 kDa and L chains approximately 27 kDa (Kaattari and Piganelli 
1996). There have been reports by other investigators of the monomeric form coexisting 
with a tetrameric form in sera (Acton et al. 1971; Clem and McClean 1975; Lobb and 
Clem 1981 a,b; Elcombe et al. 1985). Within the tetramer. the monomeric subunits have 
been found to associate either covalently via disulfide bonds, or non-covalentlv with one 
another (Evans et al. 1998). In mammals, the various associations of distinct monomeric 
Igs into different polymeric isotypes have been extensively described (reviewed in Max 
1998).
The Ig binding site is generated by the association of the variable regions of the 
heavy (VH) and light (VL) chains (Fig. I). A visual representation of the antibody 
monomer reveals a Y-shaped structure in which the arms of the Y are identical and each 
arm has a copy of the V region. These two arms join and extend downwards into the 
trunk of the Y shaped structure, which is composed of the constant regions of the heavy 
chains. Possession of many different V domains (sequences with different specificities) 
confers the ability of the system to respond to numerous different antigens. The total 
number of variable regions for either H or L chain proteins is in the hundreds in the 
mammalian system (Blackwell and Alt 1988). Enormous diversity in binding sites is not
4
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Figure I. Schematic of an antibody molecule. A. The association of heavy (H) and light 
(L) chain, each comprised of a variable (green) and constant (blue) region. H and L chain 
complementarity determining regions (CDRs) interact to form a functional antigen- 
binding site (indicated by colored circles). Two H chains and two L chains are linked by 
disulfide bonds (indicated by black lines) to form a monomeric antibody molecule. B. 
Teleost antibodies are tetrameric and consist of eight H chains and eight L chains linked 
by disulfide bonds.
5
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surprising if one recognizes the necessity of producing antibodies capable of 
accomodating the myriad number of possible foreign antigenic structures associated with 
pathogens (Kaattari and Piganelli 1996).
Variability is particularly great within the short stretches of the VH and VL 
domains called complementarity determining regions (CDRs). There are three such 
CDRs in the VH (approximate location at amino acid positions 31-35. 50-65, and 95-102) 
and three within the VL (approximate location at positions 24-34, 50-56, and 89-97) (Wu 
and Kabat 1970). Flanking each CDR is a framework region (FR) which is relatively 
invariant and maintains the CDRs in the requisite conformation for binding antigen.
Thus, if one aligns the sequences of heavy or light chains from a variety of antibodies, 
one finds tremendous variability between all of the chains at the amino acid positions of 
the CDRs. each reflecting the uniqueness of its own binding site for antigen.
In summary, a number of mechanisms have evolved to diversify the primary Ig 
repertoire. That this is achieved by the rearrangement of variable, diversity (D), and 
joining (J) segments of the variable region gene and the association of the variable region 
gene with a constant region gene was first described by Tonegawa (1983) (Fig. 2). This 
process wherein each B cell randomly splices V, D, and J together such that, throughout 
the entire population of B cells, millions of possible antigen binding sites are formed 
from relatively few VH gene segments is called somatic recombination. Additionally,
7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 2. Ig H gene rearrangement. According to the transiocon model of Ig gene 
arrangement, multiple VH gene segments are arranged 5’ proximal to the group of 
multiple DH genes and JH genes with the CH genes at the 3’ end. The number of VH, 
DH, JH. and CH genes is species-dependent. A single VH, DH, JH, and CH gene 
rearrange and are joined to produce the coding sequence for an individual antibody heavy 
chain protein. The VH segment encodes the FR1, CDR1, FR2, and CDR2 portion of the 
heavy chain and the DH and JH encode the CDR3 and FR3 portion. Other molecular 
processes allow for the insertion or deletion of additional nucleotides during this event 
but are not depicted in this simple schematic.
8
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each B cell can form an antibody from the association of any of its possible H and L 
chain combinations (combinatorial association). This random selection of VL and VH 
further increases the heterogeneity of possible binding sites. Another mechanism of 
binding site diversification, called gene conversion, is by birds and occurs via non- 
reciprocal genetic recombination and generally employs a donor pool of V 
pseudogenes located upstream of the rearranged V gene (McCormack et al. 1991; 
Reynaud et al. 1987). Finally, the binding site, regardless of how it was generated, may 
be altered by the process of somatic mutation (Berek and Milstein 1987). This process 
modifies the sequence by the introduction of point mutations or insertions / deletions 
(Wilson et al. 1998; Ohlin and Borrebaeck 1998) in CDRs. In mice, these mutations are 
introduced during clonal proliferation, at an apparent rate of -10 '3 base pair (bp)'1 
generation'1 (Maizels 1995).
Different species use one or more of these diversification pathways. Humans and 
mice generate the majority of their antibody diversity through the rearrangement of 
multiple V(D)J gene segments (Alt et al. 1987; Max 1998). Additional diversity can be 
generated junctionally and through terminal deoxynucleotidyl transferase additions 
(Landau et al. 1987). Swine also appear to rely heavily on rearrangement and their Ig 
sequences are remarkably similar to humans (Butler et al. 1994). The best studied 
example of gene conversion as a primary mechanism of diversification is the chicken
10
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(Reynaud et al. 1987). Other studies indicate that sheep use untemplated somatic point 
mutations to diversify light chain genes within the follicles of the ileal Peyer’s patch 
(Reynaud et al. 1991). Rabbits have been shown to use a limited and preferential 
rearrangement strategy (Knight and Becker 1990) coupled with a combination of gene 
conversion and untemplated somatic point mutations (Weinstein et al. 1994) to diversify 
the primary repertoire. Ectothermic vertebrates such as shark (Greenberg et al. 1995: 
Marchalonis et al. 1993; Shamblott and Litman 1989), Xenopus (Hsu et al. 1989: 
Schwager et al. 1989), and teleost fishes (Warr 1995) rely on the same strategies used by 
endotherms to diversify their primary antibody repertoire.
The molecular organization of the Ig heavy chain locus has been reported in 
various species, from sharks and rays to mice and humans (reviewed in Pilstrom and 
Bengten 1996). All VH genes to date exhibit remarkable structural and organizational 
similarities in their coding regions as well as similarities in their non-coding regions 
(Litman et al. 1983, 1985; Schwager et al. 1989: Matsunaga et al. 1990; Wilson et al. 
1991) including regulatory sequences and recombination sequences (Fig. 3). The unique 
organization of this locus in various taxa has been observed (reviewed in du Pasquier and 
Flajnik 1998).
In Chondrichthyes a multicluster organization has been reported, with clusters of 
(VH-D-D-JH-CH)n and (VH-D-JH-CH)n repeated about 100 times in the genome
II
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Figure 3. Features common to most vertebrate VH genes.
12
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Common features of Ig VH genes include:
5' promoter region which possesses a conserved octamer consensus sequence 
ATGCAAT and a TATA box. The only exception to this are the elasmobranchs.
N-terminal leader sequence consisting of an 18-20 amino acid hydrophobic coding region 
interrupted by an 80-120 base pair intron.
The variable region of approximately 98 codons which encodes 3 FRs and 2 CDRs. 
with FR1 and FR3 each containing a cysteine required for intra-chain disulfide bonding.
3* recombination signal sequences (RSS) responsible for recombination (VH-D joining) 
consisting of a heptamer motif. 22 or 23 bp spacer, and a nonomer motif.
13
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(Harding et al. 1990: Kokubu et al. 1988). All evidence suggests that rearrangement 
occurs within and not between these clusters, which has led some investigators to propose 
that diversity generated through somatic mutation preceded diversity obtained by 
combinatorial association of gene segments (Hinds-Frey etal. 1993). Teleosts have their 
H-chain encoding sequences organized in the translocon fashion (from which individual. 
D. and J genes must rearrange to produce one V(D)J segment) and during which the D 
and J segments fuse to create the CDR3 and, thus, its uniquely high degree of variability. 
This translocon organization of Ig genes is a feature shared by teleosts, amphibians, and 
mammals, although each of these taxonomic classes possess varying numbers of V, D, J, 
and C genes (reviewed in du Pasquier and Flajnik 1998) (Fig. 4).
The two teleost species whose VH repertoires have been most extensively 
characterized are the rainbow trout (Oncorhynchus my kiss) and channel catfish (Ictalums 
punctatus). These species have more than 100 VH genes as determined from Southern 
blot analysis (Andersson and Matsunaga 1995; Ghaffari and Lobb 1991; Roman and 
Charlemagne 1994; Ventura-Holman et al. 1994; Warr etal. 1991). The VH genes 
within a species are usually grouped into families of related sequences where a family is 
defined as sharing at least 80% nucleotide identity (Brodeur and Riblet 1984). In humans 
there are seven VH gene families (Matsuda et al. 1993; van Dijk et al. 1993), in the 
mouse fifteen (Tutter et al. 1991; Tutter and Riblet 1989), in rainbow trout at least eleven
14
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Figure 4. Organization of Ig genes in various phylogenetic classes. Illustrated is the 
multicluster organization of the Elasmobranchs, compared to the translocon organization 
of Teleosts. Amphibians, and Mammals.
15
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(Roman et al. 1996) and in channel catfish six VH gene families have been described 
(Ghaffari and Lobb 1991: Ventura-Holman et al. 1994: Warr et al. 1991). The similarity 
in the numbers of VH families among these phylogenetically distant groups (teleosts and 
mammals) is striking - why should fish have as many VH gene families as higher 
vertebrates to mediate what has been described as a restricted antibody response? Other 
teleosts have also been studied in this respect although less thoroughly. Atlantic cod 
{Gadus morhua) has at least three families with 10-20 members of each family (Pilstrom 
et al. 1996). The goldfish (Carassius auratus) has also at least three different families 
(Wilson et al. 1991) and the ladyfish (Elops saums) has at least two families (Amemiva 
and Lit man 1990).
VH Gene Utilization During an Antigen-Specific Immune Response
The generation of an effective antibody response, even with somatic mutational 
modifications is highly contingent on the germline composition of the VH complex. VH 
gene identification has been instrumental in the elucidation of the requirements for 
prophylactic immune responses (Kofler et al. 1992, Chung et al. 1995, Leclerq et al.
1997, Sun et al. 1999, Toran et al. 1999), the mechanisms of antibody-mediated 
immunopathology (Bona 1988. Spatz et al. 1990, Hoch and Schwaber 1996), and the 
ontological acquisition of antibody specificities (Perlmutter et al. 1985, Alt et al. 1987,
17
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Jeong and Teale 1988). With respect to prophylactic immunity, for example, the use of a 
single human germ line VH gene (DP50) appears to be responsible for generating the 
highest affinity antibodies to a critical antigen of HIV. gp 120 (Toran et al. 1999). These 
antibodies are thought to be responsible for long-term survival and protection against this 
virulent pathogen. Another important feature of VH genes is the role different allelic 
forms, or polymorphisms, can play in determining resistance or susceptibility to disease. 
Leclerq et al. (1997) demonstrated, through the use of isogenic and congenic mice, that 
the ability to produce a neutralizing antibody to the poliovirus capsid protein epitope (C3) 
is linked to loci within the VH complex. In these studies, mice bearing specific VH- 
associated haplotypes were unable to produce antibodies which could effectively bind 
this epitope and neutralize the virus. Thus, only certain alleles expressed at this locus can 
result in prophylactic antibodies, while others are ineffectual to the same pathogen. This 
polymorphic effect is likely to be of even more importance to a fish such as the rainbow 
trout, in which the antibody repertoire is known to be more limited than that of mice or 
humans (Wetzel and Charlemagne 1985, Cossarini-Dunier et al. 1986. Desvaux et al.
1987. Hastings and Ellis 1988).
These findings have serious implications for the development of fish vaccines. It 
is possible that certain vaccines, particularly subunit vaccines (Dertzbaugh 1998), may 
not be capable of effectively immunizing large, genetically diverse populations of fish if
18
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the VH repertoire is small. If this proves to be the case, a more efficacious method of 
vaccine development would be to first identify the specific VH alleles which can be 
associated with a particular disease resistance and fashion probes for these VHs to 
ascertain which populations could conceivably benefit from specific vaccines. 
Additionally, such probes could be enormously valuable genetic markers to be used in the 
breeding and development of disease resistant stocks.
The VH germline repertoire is also important in providing a unique substrate 
from which certain specific mutations are possible. Such can be seen with the response 
to an epitope, phosphorylcholine (PC), which relies on a very restricted VH family. 
Phosphorylcholine is a primary epitope found in the polysaccharide antigens of a wide 
variety of pathogens including Streptococcus (Bennett and Bishop 1977; Jennings et al. 
1980; Claflin and Berry 1988), Proteus (Claflin et al. 1987), fungi, and parasitic 
nematodes (Pery et al. 1979; Choy et al. 1991). Interestingly, in the mouse, antibody to 
this critical epitope initially employs one gene family (S107) which contains only one 
VH gene (Crews et al. 1981). Although the VH repertoire appears limited, anti-PC 
antibodies can be the primary protection against diseases such as bacterial pneumonia 
(Chen et al. 1995). However, considering the restricted repertoire, it would stand to 
reason that any allelic polymorphism akin to that discussed above could result in global 
differences in antibody reactivity to a variety of pathogens. This might be the case, were
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it not for the process of somatic mutation which expands the antibody repertoire, often 
using this single gene as the substrate for the mutational process. As this is a genetically 
simple system, it has provided deep insights to the power of somatic mutation in molding 
the immune response capacity of an animal (Stenzel-Poore and Rittenberg 1989; Chen et 
al. 1995). Rittenberg and co-workers (1989) have elegantly demonstrated that although 
the early murine response is dominated by the progeny of the S107 VH gene, the eventual 
induction of mutations within an alternate lower affinity VH germline gene results in an 
even more aptly suited, high affinity antibodies late in the response. These progeny of 
low affinity progenitors eventually come to dominate the anti-PC response through 
antigen-driven selection via their newly mutated, high affinity receptors. Precise 
knowledge of the germline VH repertoire, thus, also becomes essential in determining if 
and when somatic mutation occurs and within which VH genes.
The developmental acquisition of antigen specificities has also been found to be 
contingent on VH gene family position and composition and specific VH gene family 
utilization against a number of antigenic epitopes have been identified in the murine 
model (Table I) (Crews et al. 1981; Fougereau et al. 1984; Dzierzak et al. 1985;
Minoprio et al. 1989; Clarke et al. 1990a, b; Victor-Kobrin et al. 1990; Miller et al. 1996; 
Zinkemagel and Hengartner 1996; Clemons et al. 1998). Both in mice (Perlmetter et al. 
1985; Alt et al. 1987; Jeong and Teale 1988) and humans (Schroeder and Wang 1990;
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Table I. Antigen specificities which have been associated with specific VH gene 
family utilization in the murine model.
Antigen VH family
Phosphorylcholine S107
3-2, 6 fructosan X24
a-1, 3 dextran J558
S. dysenteriae 0  antigen 36-60
T. cmzi 7183, S107
Vesicular Stomatitis Virus Q52
(primary response) 
Vesicular Stomatitis Virus Q52, 7183,
(secondary response) J558
Influenza hemagglutinin 36-60
Trinitrophenyl (TNP) 36-60
GAT copolymer J558
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Gruwunder et al. 1995), the ability to employ specific VH genes is restricted 
ontologically to specific VH families. Studies thus far have indicated that murine VH 
families that are more DH proximal are incorporated earlier within the expressed 
antibody. Again, this phenomenon will likely have important implications for salmonid 
diseases such as IHNV where disease susceptibility is greatest in fry or young fish 
(Evelyn 1997). This susceptibility is not due to a general lack of immunocompetency as 
antibodies can even be produced in yolk sac fry (Castillo et al. 1993). Therefore, it is 
possible that EHNV susceptibility may be due to the selective early developmental 
acquisition of VH specificities which are non-essential to the anti-IHNV response.
Unfortunately, the current status of our knowledge of the trout VH genes and their 
encoded specificities is woefully insufficient to be of benefit to the aquaculture industry. 
Of critical relevance, no studies, to date, have attempted to determine the antigen 
specificity encoded by trout VH genes (Roman and Charlemagne 1994; Andersson and 
Matsunaga 1995; Roman et al. 1996; Widholm et al. 1999). All cloning and sequencing 
efforts have used primers derived from various consensus sequences, without regard to 
their probable specificity, and they are often based on sequences from phylogenetically 
distant species.
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The Mechanism of Somatic Hypermutation
Although the process of somatic mutation clearly contributes to the generation of 
diversity of antibody structure, the actual mechanism has as yet to be described. In fact, 
there may be any number of enzymatic systems capable of introducing mutations. A 
system with G-C base pair preference that introduced mutations at a low frequency (10'3) 
in a rearranged ja gene under the control of a 3 ’ cis-acting enhancer has been reported 
(Bachl and Wabl 1996). However, this mechanism would not account for the observed 
bias to replace purines or pyrimidines with purines (Neuberger and Milstein 1995;
Domer et al. 1997) or to explain the full spectrum of mutations noted. Two other models 
suggest either (1) a mechanism with strand polarity that targets random base pairs for 
mutations to a purine or (2) a mechanism that targets purines on both the sense and 
antisense strands. The first would better support the finding that both purine transitions 
and pyrimidine tranversions are favored. Indeed, the evidence cited in the literature is 
more consistent with a mutational mechanism that exhibits strand polarity (Both et al. 
1990; Yelamos et al. 1995; Peters and Storb 1996). A reverse transcriptase (RT)-based 
mechanism was proposed by Steele and Pollard in 1987. The basic tenet of this model 
(the RT-mutatorsome model) is that the mRNA of the rearranged V(D)J is reverse 
transcribed in an error-prone manner to cDNA and then recombined homologously into 
the genome. This contrasts with the previously described alternative mechanisms which
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are classed as DNA-based mechanisms. Steele etal. (1992) argues that a model involving 
reverse transcription best explains the experimental evidence of somatic mutation without 
the ad hoc assumptions which predicate the DNA-based mechanisms.
One impediment to the identification of the mechanism of somatic hypermutation 
has been the lack of an in vitro system to study this process. Recently, however, it has 
become possible to initiate somatic mutation in vitro by activating a Burkitt’s lymphoma 
cell line through cross-linking of the receptors. By co-culturing these cells with an 
activated T cell line, B cells will proliferate and accumulate somatic mutations (Kiillberg 
et al. 1996). Another strategy, described by Razanajaona and colleagues (1997), involves 
the co-culture of naive tonsillar B cells and activated T cells which also has been shown 
to induce in vitro triggering of somatic mutation. Another strategy to investigate the 
molecular mechanism underlying somatic mutation has been the analysis of somatic 
mutation in transgenic and transfected target genes (Storb et al. 1996).
Essential Features of Somatically Mutated V(D)J
Although somatic mutation has been identified in the homed shark, Heterodontus 
fransciscii (Hinds-Frey et al. 1993) and Xenopus laevis (Wilson et al. 1992, 1995), basic 
research into this process as it occurs in lower vertebrates has not been investigated to the 
extent that it has been followed in mammals. In fact, many of the observed somatic
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mutation patterns observed in ectothermic vertebrates contrast the patterns observed in 
mammals (Wilson et al. 1995). As summarized by Steele et al. (1997), there are essential 
features of somatically mutated V(D)J which have been identified in mouse and man 
(Table II).
These essential features, it must be emphasized, have been identified in warm­
blooded vertebrate animal models and when common features of somatic mutation in 
cold-blooded vertebrates are considered a number of differences may occur. A survey of 
somatic mutational changes observed in Xenopus and homed shark reveal a striking 
preference for GC compared to AT bases, with a preference for transitions over 
transversions (du Pasquier and Robert 1992). Xenopus Ig genes, like their mammalian 
homologues, contain sequence motifs (A/G G C7T A/T) reported to target the mutational 
machinery (Schwager et al. 1989: Wagner and Neuberger 1996) (discussed in detail next 
section).
Intrinsic vs. Antigen-Selected Mutational Hotspots
Studies on the mechanism(s) of somatic mutation have been complicated by the 
fact that only those mutations that lead to high affinity antibodies will be selectively 
expanded upon interaction with antigen. This skews the profiles of the original or 
unselected / unbiased, mutated genes. To examine these original, unbiased mutations,
25
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Table II. Features of somatically mutated V(D)J.
Unrearranged V elements do not undergo somatic mutation.
Isotvpe class switching is not required for somatic mutation to occur, although 
more mutations have been observed in V(D)J expressed as IgG or IgA.
The 5' boundary for somatic mutation is located at or near the transcription start 
site for VH and in the leader-VL intron for VL.
The 3’ boundary for somatic mutation for VH and VL terminates in the J-C intron 
near the intron-enhancer/matrix attachment region (Ei/MAR).
Sequences in the J-C intron near the Ei/MAR appear necessary for somatic 
mutation to occur.
V segments in the V(D)J can be replaced by non-Ig DNA and still hypermutate.
The somatic point mutation rate is 10-3 bp*1 generation1 with a frequency of 1- 
5% in the V(D)J target region; up to 1 nucleotide per 20 can be mutated.
Mutational bias is for transitions over transversions in the murine model.
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without the influence of antigen-directed selection, non-productively trangenes were 
analyzed (Domer et al. 1997). With the nonproductive rearrangements, antigen selection 
does not contribute to the proliferation of somatically mutated B cells, as the antibodies 
are not expressed on the lymphocyte surface. The results of these studies and others, 
including those of Betz et al. (1993, 1994) and Neuberger and Milstein (1995) clearly 
indicate the presence of commonly shared mutational hotspots. These hotspots are not at 
a conserved distance from the transcriptional start site, and seem to be a consequence of 
local DNA sequence. Many of these hotspots occur in serine AGC/T triplets, whether 
they are in frame or not. Serine AGC/T codons are almost exclusively targeted for 
somatic mutation in comparison to the more commonly occuring TCN serine codons 
(where N is any nucleotide) (Neuberger and Milstein 1995). One of the most commonly 
cited examples of this, by Betz et al. (1993), is the VkOx-1 Ser31 hotspot at the tip of a 
potential stem-loop structure TGTAA>G<TTACA. The involvement of secondary 
structure considerations such as this have also been reported by Golding et al. (1987) in 
which nearby direct repeats or palindromic sequences have been observed which could 
serve as potential templates for alteration.
The second base of the AGC/T codon has been seen to mutate to any of the other 
nucleotides, A/C/T, in a manner consistent with a ratio predicted by intrinsic substitution 
preferences (Betz et al. 1994). To contrast this with a commonly described antigen-
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selected hotspot, the His34 (CAC) of VkOx-1 is characteristically mutated by 
transversion to Asp (GAC). As previously noted, intrinsic point mutations show a bias 
towards transition substitutions. Antigen-selected hotspots can generally be 
discriminated from intrinsic hotspots by their tendency towards a mutation (Betz 1993) 
which leads to a structurally improved area of contact for subsequent binding of antigen 
and. thus, the selection and expansion of cells possessing this mutation when exposed to 
this relevant antigen. Per the observations of Betz and others, CAGCT and AAGTT are 
sequence motifs which are characteristic of intrinsic targets. Independent of these 
findings by Betz, Rogozin et al. (1992) performed a statistical analysis of the sequences 
of hypermutated antibodies in which they neither restricted the analysis to major hotspots 
nor excluded the effects of antigen-selected mutations and found that the sequences TAA 
and RGWY (R=purine, Y=pyrimidine, and W=A orT) are preferred sites of mutation. 
The Betz sequences are more specific but both lie within the RGWY consensus sequence. 
Most recently, Domer et al. (1998) refuted the contention that the somatic mutational 
machinery exhibits DNA strand polarity as analyses of the mutation rate of the inverse 
repeat of RGWY, WRC Y (and the inverse repeat of other mutational hotspot sequences) 
revealed a similar mutation frequency.
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The Role of Somatic Mutation in Affinity Maturation
The specificity of the antibody response to a pathogen ultimately determines the 
effectiveness of the response and, in many instances, whether an animal will be protected 
or succumb to the disease. As such, an antibody response, even a single antibody’s 
specificity, or affinity, for the specific antigen cannot remain a static feature. The 
expressed affinity of antibodies induced during an immune response is the product of a 
dynamic process termed affinity maturation (Eisen and Siskind 1964; Berek et al. 1985). 
Affinity maturation refers to the increase in overall affinity of serum antibodies in 
response to antigen over time. There are two distinct yet interactive processes which lead 
to the development of affinity maturation. First, upon exposure to antigen, B 
lymphocytes which have bound sufficient antigen via their surface Ig receptors are 
triggered to proliferate and secrete antibodies, possessing the same binding site as that 
expressed by the surface immunoglobulin (Burnet 1969; Siskind and Benacerraf 1969). 
During the immune response the initial in vivo antigen concentration is relatively high 
and thus stimulates B lymphocytes possessing both high and low affinity antibody 
receptors. However, as the concentration of antigen declines over time, B cells with 
higher affinity receptors will be selectively stimulated as the low affinity B cells will be 
unable to bind sufficient antigen to trigger a proliferative response (Goidl et al. 1968).
This process is fundamentally antigen-driven. However, somatic mutation can
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greatly enhance affinity maturation. In the most extensively studied species (mouse), it 
has been observed that towards the end of the primary antibody response, affinity 
increases surpass those observed during the primary response (Griffiths et al. 1984:
Kocks and Rajewsky 1988). These increases are attributed to the accumulation of 
somatic mutations within the genes encoding the V regions of the antibody genes of 
activated B cells. Few mutations actually lead to a structural change in the binding site 
which generates an antigen receptor with increased affinity. However, when this occurs 
these higher affinity variants have a selective advantage in being triggered by antigen 
(Wysocki et al. 1986). Studies using syngeneic mouse strains, coupled with the use of 
hybridomas have elegantly demonstrated this phenomenon (Berek and Milstein 1987). In 
these studies the investigators primed and challenged mice with 2-phenyloxazolone and 
at various points during the response sacrificed individuals and fused the lymphocytes to 
produce hybridomas. These hybridomas provided the opportunity to analyze individual 
VH sequences responsible for the production of the specific monoclonal antibody. In this 
way the precise affinity of the monoclonal antibody was determined and could be 
associated with a specific VH sequence. These studies revealed a number of important 
features of this process. First, the number of hybridomas expressing specific monoclonal 
antibodies became skewed over time towards the higher affinity monoclonals. Further, 
the increases in affinity could be directly related to the appearance of hybridomas
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expressing somatic variants. However, as the response matured the number of mutations 
detected increased considerably, often in cells which had accrued very specific mutations 
early in the response. The use of syngeneic animals and hybridomas has facilitated the 
delineation of somatic mutation lineages and their effect on antibody affinity. 
Unfortunately, the technology for the production of piscine hybridomas and monoclonal 
antibodies does not exist, and analysis of antigen-specific B cells in fish must involve 
some means of immunopurification in order to derive Ig VH mRNA for subsequent 
manipulation and analysis.
Affinity Maturation and Somatic Mutation in Xenopus and Shark
Antibody responses of ectothermic vertebrates do not mature in the same fashion 
as responses analyzed in mice. This has been evidenced by either a total lack of affinity 
maturation in some species or a lower increase in affinity in others. When it was 
determined that all ectotherms studied possess a large number of V(D)J genes, and that 
rearrangement processes to establish Ig repertoires are essentially the same as those in 
mouse and human, it was theorized that poor immune responses in ectotherms could be 
explained by a suboptimal utilization of somatic mutants (du Pasquier 1982, 1993). 
Alternatively, it was posed that somatic mutation arose late in vertebrate evolution, after
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emergence of the rearrangement process that generates functional V genes (Matsunaga
1985).
Xenopus is the only ectothermic vertebrate in which the development of somatic 
mutations has been investigated during the course of an antigen-specific immune 
response (Wilson et al. 1995). The V heavy chain gene family involved in the anti- 
dinitrophenyl (DNP) response was well-known (VH1: Schwager et al. 1989) from 
previous sequencing of anti-DNP antibodies (Brandt et al. 1980); thus, one could monitor 
VH1 gene expression during an ongoing anti-DNP response in isogenic Xenopus 
tadpoles. All VH1 genes (32 in total) present in a single haplotype were sequenced and 
only a small number of mutation s were noted (Wilson et al. 1992). On average, 1.6 
mutations per gene was observed and there was no strong selection for mutations in the 
CDR1 and CDR2 . Although CDR3 is generally the region most likely to accumulate 
replacement point mutations (Johnson and Wu 1998), virtually no point mutations were 
detected in the Xenopus CDR3. One theory proposed by Wilson in this study was that 
while the frequency of somatic mutations was lower than that found in antigen-specific 
mammalian B cells, quantitative differences would be equalized when one considers 
overall mutation rates. Taking the generation time of a Xenopus lymphoid tumor cell line 
as the basis of the calculation, the rate of somatic mutation appeared to be quite similar to 
that found in mammals during an antigen-specific response. Wilson's observed Xenopus
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IgM mutation rates of 2.5xl0~*per bp per generation to 4.1xl0'5 per bp per generation are 
only four to seven times lower than the highest levels reported in hyperimmunized mice 
(du Pasquier and Robert 1992).
What, then, accounts for the relatively poor affinity maturation of the ectothermic 
vertebrate antibody response as compared to that observed in mammals? Although some 
differences in the essential features of somatic mutation are observed in ectothermic 
vertebrates, the primary difference may involve the selection process. It has been 
suggested (du Pasquier 1982; Wilson et al. 1992) that mutated B cells are poorly selected 
in the lymphoid organs of Xenopus and other ectothermic vertebrates because germinal 
centers (GCs), well known for their role in orchestrating the generation and selection of 
mutants in mouse and human (MacLennan 1994) are apparently absent in these species 
(Zapata et al. 1995). If true then Xenopus and homed shark somatic variants would likely 
bear the hallmarks of this poor selection. One strong indication that this might be the 
case was the observation that in spite of some of the clustering of the mutations in the 
CDRs, the rate of replacement to silent mutations (R:S) in Xenopus and homed sharked 
Ig were not increased significantly in CDR over FR. However, in (non-immunized) 
rainbow trout the analysis of VH gene diversity in cDNA clones has shown that both 
replacement and silent mutations occur more frequently in CDRs (Matsunaga and 
Andersson 1997).
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It is difficult to reconcile how germline V products can be selected in a specific 
primary response lacking a physical microenvironment such as that which occurs in GCs, 
but selection of Xenopus B cells appears obvious as a specific immune reponse can be 
engendered. This is evidenced by the differences observed in the Xenopus primary and 
secondary immune response. If the lack of a selective environment (i.e. germinal center) 
inhibits the recruitment of somatic mutants, why do Ig genes in Xenopus and homed 
shark (and by extension, all ectotherms) B cells mutate at all in the course of an antigen- 
specific response? One possibility is that the mutational mechanism originally arose in 
evolution to modify Ig genes that did not rearrange (du Pasquier 1982; Wagner and 
Neuberger 1996). In certain cases, such as with sheep, somatic mutation may simply be a 
mechanism by which the primary repertoire can be expanded, even from a single VL 
gene (Reynaud et al. 1991). Thus, in mature frog and shark B cells undergoing an 
antigen-specific response, the mutational mechanism may be expressed neotenically (in 
an evolutionary sense) perhaps in a similar fashion to re-expression of RAG genes in 
mouse germinal center B cells (Han et al. 1996). It is possible that the generation of 
mutants, in the absence of an efficient selection mechanism, may still provide animals 
with an expanded and potentially useful repertoire.
Indeed, if germinal centers play such a key role in selection, then GC-deficient 
mammals should not be capable of affinity maturation. However, this is not the case
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when examined experimentally. Two different GC-deficient murine models have been 
identified: lymphotoxin a (Lta) and CD 19 knock-out (KO) mice. That these KO mice 
are GC-deficient was happenstance and not the original motivation for their production. 
In the Lta KO (Matsumoto et al. 1996) it was suggested that antibody affinity maturation 
occurs without germinal centers as the immunized mice had the same somatic mutations 
that are typically detected in responses of wild-type mice, and R:S ratios seemed, 
according to the authors, to indicate a selection of mutants in the CDR. However, given 
the number of mutants analyzed in these mice, the R:S ratio is not significantly different 
from that expected without selection (4.9 vs. 7.7, p> 0.3). Moreover, affinity maturation 
was estimated neither by equilibrium dialysis nor a step-wise titration of an inhibition of 
the antigen-antibody reaction. Instead, a rather imprecise estimation of low or high 
affinity was based on a four-fold level of hapten substitution of the test antigen only. In 
other words, the GC-deficient Lta KO model may have indeed recapitulated the situation 
in ectotherms. In contrast to the Lta KO mouse, the CD 19 KO also lacked germinal 
centers but showed no evidence of affinity maturation (Rickert et al. 1995). Analysis of 
the Lta KO and wild-type mouse somatic mutations revealed that 65 out of 110 mutations 
(59%) affected a G or C in the wild-type mouse, whereas in the KO mouse the ratio was 
32/41 (72%). This is a significant trend towards GC bias and is consistent with the 
somatic mutation patterns seen in ectothermic vertebrates. Thus, the GC bias that is not
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generally observed in mammals may be a function of poor selection and bears additional 
investigation.
Perhaps trout do possess a localized microenvironment capable of selecting B 
cells possessing Ig receptors with increased affinity. A unique feature of piscine 
lvmphomeloid tissue is the presence of melanomacrophage centers in the kidney, spleen, 
and liver (Kennedy-Stoskopf 1992). These melanomacrophage centers may be the 
forerunners of the germinal centers present in the spleen and lymph nodes of birds and 
mammals (Agius 1985). Both melanomacrophage centers and germinal centers are 
aggregates of reticular cells, lymphocytes, macrophages, and plasma cells. Espenes et al. 
(1995a) has suggested that ellipsoids found in the anterior kidney and spleen of rainbow 
trout may contribute to the processing of trapped immune complexes in these fish and 
others. Ultrastructural studies in trout (Espenes et al. 1995a) and enzyme histochemical 
studies in Atlantic salmon (Press et al. 1994) have demonstrated that salmonid ellipsoids 
contain macrophages that are active in phagocytosis of foreign particles. The observed 
immune-complex trapping in immunized trout suggests a specific role for splenic 
ellipsoids in rapid delivery of antigen to the peri-ellipsoidal leukocyte populations in a 
secondary immune response (Espenes et al. 1995b). Studies have indicated that the 
salmonid spleen contains a mature and heterogeneous B cell population (Irwin and 
Kaattari 1986) and a recirculating T cell population (Tatner and Findlay 1991). Efficient
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delivery of antigen to these cells may contribute to the increased sensitivity to antigen 
observed in primed rainbow trout. However, further studies are needed to determine the 
contribution of immune-complex trapping in ellipsoids to the propagation and regulation 
of the piscine immune response.
Affinity Maturation and Somatic Mutation in Teleost Fish
Little work has been forthcoming on affinity maturation or somatic mutation in 
fish. Studies in our laboratory have demonstrated that the antibody response to TNP can 
increase over 10-fold (Kaattari and Shapiro 1994; Shapiro 1995: Shapiro et al. 1996; 
Khor 1996). Using a solid phase, affinity-based method (described below), not only can 
the average affinity of the serum antibodies be determined, but the development of 
specific high affinity subpopulations can be distinguished and quantified. This analysis 
revealed the emergence of new, high affinity subpopulations late in the immune response 
(Khor 1996, Fig. 5) This is in contrast to certain other studies in the catfish (Lobb, 1985), 
Atlantic salmon (Killie et al. 1991) and Pacific salmon (Voss etal. 1978). Unfortunately, 
in these latter studies, serum affinities were first determined 2 -3  months post 
immunization. These relatively late sera were subsequently compared to even later sera 
to determine if affinity maturation had occurred. Studies performed by Ing Wei Khor, 
Haili Zhang, and others in our laboratory and in other laboratories (Cain et al. 2000;
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Figure 5. Comparison of anti-TNP titers with average affinity sub-population values.
A. Mean antibody titer against TNP (units of activity pi'1 plasma) is shown to increase 
between week 5 and 10 post primary immunization, then maintain at the same level at 
week 20 and start to decrease at week 25. B. While TNP titers begin to decrease at week 
25 post primary immunization, the mean weighted average affinity (aK) is maintained at 
the same level at week 25 (Khor 1996).
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Solem et al. 2000) have indicated that substantial affinity maturation does, in fact, occur 
between 5 and 10 weeks post primary immunization. Therefore, the earlier studies may 
have been attempting to detect an antibody affinity shift after it had already occurred. 
Our studies have revealed that the affinities measured by these investigators (Ka= 4.3 x 
105 M'1 to 8.4 x 105 M 1) are not unlike average affinities which we observed at 
approximately the same time point, however we observe that Ka values prior to this time 
are considerably below 1.0 x 105 M '1.
As a rule, little affinity maturation has been detected in fish, although some 
changes in fine specificities have been noted in trout (Arkoosh and Kaattari 1991). The 
diversity of binding sites has been addressed by a number of methods such as the use of 
Scatchard analysis of whole serum antibodies (Shankey and Clem 1980), relative 
specificity analysis (Makela and Litman 1980), IEF of immunopurified antibodies 
(Cossarini-Dunier et al. 1986; Wetzel and Charlemagne 1985) and anti-idiotypic analysis 
(Richter and Ambrosius 1988). In all cases the studies have indicated that little 
heterogeneity of binding sites exists among the fish species. However, limited 
heterogeneity is also true for mammalian IgM (Griffiths et al. 1984). These observations 
led to the intriguing speculation that the need for the expression of monomeric Ig may 
have led to the development of mechanisms to produce binding sites with high intrinsic 
affinity and perhaps a greater repertoire of binding sites. Supportive of this hypothesis is
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the observation that sharks, which possess a monomeric form of Ig, appear to develop the 
same high intrinsic affinity in this class of Ig as do their monomeric mammalian 
counterparts (Voss and Sigel 1972).
Affinity Maturation and Development of an Effective Anti-Viral Response
Protection against various viral diseases has been directly associated with the 
acquisition of high affinity antibodies to viral epitopes (Steward 1981; Steward et al.
1991; Brostrom et al. 1995; Chargelegue et al. 1995). Of particular relevance to this 
study, which deals with a fish rhabdovirus (IHNV), is the dependence on mutationally- 
derived high affinity antibodies to vesicular stomatitis virus (VSV) (Kalinke et al. 1996) 
and rabies virus (Ikematsu et al. 1993). Such processes have also been noted in influenza 
responses (Clarke et al. 1990a. 1990b) and responses to hepatitis B virus (Andris et al. 
1992). The requirement for high affinity antibodies to halt disease progression has been 
observed during human immunodeficiency virus (HTV) infections. Patients who 
demonstrate a marked progression of the disease lose high affinity antibodies to a critical 
neutralizing epitope of gpl20. This occurs even though the overall antibody titer remains 
unchanged. Some investigators have postulated that this loss of high affinity antibodies 
could be due to a helper T cell dysfunction (Chargelegue et al. 1995). The rapid 
generation of high affinity antibodies to cytomegalovirus in humans has also been shown
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to be impaired when patients are exposed to exogenous immunosuppressive therapy, 
indicating the critical role of T cells in the development of high affinity anti-viral 
antibodies (Lutz et al. 1994). Impairment of T helper cell (CD4) interactions with B cells 
when responding to antigen also leads to inability to undergo somatic mutation and 
express high affinity antibodies (Lane et al. 1994). Also, although severe DiGeorge 
syndrome patients exhibit comparable use of the germline VH genes as in normal 
individuals, they exhibit a lack of somatic mutation, implicating the need for T cells in 
this process (Haire et al. 1993). These studies emphasize that affinity maturation is a 
complex process that is highly contingent upon the T-dependency of the antigen. Thus, in 
order to provide the highest affinity antibodies, vaccines must not only provide B cell 
epitopes, but epitopes which will elicit strong T helper cell function which is necessary 
for somatic mutation. The ability to monitor the induction of somatic mutations and 
affinity maturation should, therefore provide vaccinologists with important tools to assess 
the capabilities of their vaccines. This is a very fertile area of comparative 
immunogenetics research, for which the trout model is most aptly suited.
The choice of EHNV as an immunogen for the current study arises from the large 
body of research characterizing fish immune responsiveness to this viral pathogen.
EHNV is an aquatic rhabdovirus responsible for epizootics in wild and hatchery-reared 
salmonids (Groberg and Fryer 1983). It has recently been assigned a new genus
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(,Novirhabdovims) within the virus family Rhabdoviridae as it possesses a sixth viral 
gene (the non-virion protein gene) which is not found in many other rhabdovirus 
genomes (Kurath et al. 2000). This virus causes extensive necrosis of the blood-forming 
tissues of kidney and spleen (Winton et al. 1988) and results in high mortality in juvenile 
and yearling fish. The viral genome is 11,131 nucleotides in length and encodes six 
structural proteins, including the viral envelope glycoprotein (Morzunov et al. 1995). A 
cDNA of the IHNV glycoprotein has been cloned which is 1.609 bp in length and 
encodes a protein 508 amino acids long (Koener et al. 1987). This glycoprotein is known 
to elicit a neutralizing antibody response in rainbow trout (Engelking and Leong 1989).
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RATIONALE AND OBJECTIVES
Recent experimental evidenceon affinity maturation suggests that antigen specific 
somatic mutation may occur in teleost species. Further, the generation of somatic 
mutants has been observed in other lower vertebrates such as Xenopus and homed shark, 
however, these variants have not been correlated to the induction of a specific immune 
response. The development of affinity maturation and its promotion through the 
selection of somatic mutations during the immune response is a key factor in the 
development of a specific antibody response. Thus, it was the intent of this project to (1) 
assess the development of somatic mutation in trout during the antibody response against 
two different antigens and (2) ascertain their role in the affinity maturation of trout 
antibodies. Two dissimilar antigens, TNP and a synthetic 20-mer peptide epitope of 
IHNV glycoprotein, were used to assess the specificity of induction of the somatic 
mutational process.
Previous experiments (Khor 1996; Zhang 1999) demonstrated the induction of 
high affinity antibody variants to TNP during the late antibody response to TNP-KLH. 
Whether or not these were produced by somatic mutation had yet to be established.
IHNV is a devastating pathogen in salmonid populations and may quickly evolve 
resistance to an antibody response by the selection of glycoprotein variants within 
immune fish (Winton et al. 1988). In response to this evolution of the vims, the host
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itself must demonstrate plasticity in its ability to generate a neutralizing antibody 
response. Thus, somatic mutation could be critical to this counter-evolution of the 
immune response in the host. Based on these observations, the use of both antigens in 
this study would provide insight about the molecular processes occurring during the 
development of a piscine immune response.
In order to examine this process, individual trout with the highest antibody 
affinity shift response from each immunization group were identified by serological 
methods. cDNA sequences were then obtained from these individual responders to 
examine the antibody (H chain) response on the molecular level over time. This was 
done to limit the expense of obtaining cDNA sequences (ideally, 10 per each time point 
per individual). As the characterization of an antigen-specific immune response 
correlating serologic and molecular results had never before been attempted in a teleost 
species, any evidence supporting the occurance of somatic mutation would be considered 
sufficient / informative for the purpose of this study.
Thus, the objectives of this study may be summarized as follows:
• Immunize trout with TNP-KLH or IHNV glycoprotein peptide conjugated to BSA 
and identify antibody affinity shift responders by ELISA. Include as a control trout 
immunized with PBS to identify possible adjuvant effects.
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• Immunoselect high affinity B cells from hyperimmune fish during the time course of 
the experiment.
• Procure cDNA sequences and identify any somatic mutations occurring during the 
generation of the specific immune response.
• Correlate molecular results with serological results to determine whether antigen 
specific somatic mutations occur and accumulate in the trout B cell repertoire.
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MATERIALS AND METHODS
Animals
Fish in these experiments were between 250-500 g and 1+ years prior to 
immunization and sampling. They were maintained in 370 or 1500 L tanks with 
recirculating systems supplied with biological and UV-filtered well-water. Freshwater 
exchange was approximately 2% per day with 75% of the volume recirculated through 
the Filter system every hour. Water temperature was maintained at 12° C and photoperiod 
adjusted to match seasonal changes. Fish were fed a dry pellet diet (Trout Grower High 
Fat, Zeigler Brothers. Gardners, PA) and the water quality monitored daily for pH. 
alkalinity, ammonia, and nitrite levels. For identification purposes, each trout was 
implanted with a 12 mm passive radio-frequency identification tag (PIT tag) (Biomark, 
Boise, ED) which transmits a unique identification number for each animal (Table HI).
The PIT tag was implanted with a hand-held injection device which delivers the tag to the 
inter-muscular area centered approximately 1 cm below the dorsal fin.
Antigen Preparation 
TNP Preparations
Trinitrophenylated-keyhole limpet hemocyanin (TNP-KLH) was prepared as
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Table M. Identification of rainbow trout used in experiment.
# PIT tag # Treatment
1 414C5C4626 PBS-> 414C7A1853 PBS
3 4I4C70F05 PBS
4 414D0I3430 PBS
5 414C60005I PBS
6 4I4C5E0527 TNP-KLH
7 4I4C604A5A TNP-KLH
8 4I4D067515 TNP-KLH
9 414C75334F TNP-KLH
10 414D013E42 TNP-KLH
11 414F0772048 IHNV 2p peptide-BSA
12 414C73735D IHNV ip  peptide-BSA
13 414C693D10 IHNV gp peptide-BSA
14 414C617D3E EHNV gp peptide-BSA
15 414C73642E IHNV gp peptide-BSA
918 (none - from H. Zhang study) TNP-KLH
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described by Rittenberg and Amkraut (1966) for use as an immunogen (Fig. 6A).
Briefly, 5 ml of a 15 mg ml'1 solution of KLH (Sigma, St. Louis. MO) was dialvzed 
against three changes of 0.28 M sodium cacodylate buffer. After dialysis the KLH 
solution was stored in a foil-covered tube. Trinitrophenylation of KLH was 
accomplished by dissolving 16.2 picrylsulfonic acid (Sigma) in 1.5 ml of cacodylate 
buffer. This solution was added dropwise to the KLH and the solution was mixed on a 
rotator-mixer for 1 h at room temperature. The solution was dialvzed against four one 
liter exchanges of 0.7 M phosphate buffered saline (PBS), pH 7.2. Once produced, the 
TNP-KLH conjugate was analyzed spectrophotometrically to determine the haptenization 
ratio of TNP:KLH monomer (Garvey et al. 1977). The TNP-KLH prepared for these 
experiments was determined to be approximately 75 TNP per 400,000 Da monomer (373 
TNP per KLH). After preparation, the solution was filter-sterilized using a 0.22 pm filter 
(Pall Gelman Laboratory, Ann Arbor, MI) and stored in a sterile stoppered serum bottle 
at 4° C pending use. Trinitrophenylated-bovine serum albumin (TNP-BSA) was prepared 
essentially in the same manner as TNP-KLH, however, the haptenation ratio was 8 TNP 
per BSA molecule. TNP-BSA was used as the plate coating antigen for the ELISAs of 
plasma anti-TNP titration and affinity analysis.
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Figure 6. Antigens used to immunize trout. (A) TNP-KLH with a haptenation ratio of 
373 TNP per KLH. (B) A synthetic 20-mer protein epitope of LHNV glycoprotein 
(ASESREECLEAHAEIISTNS) (IHNV gp peptide-BSA) with a ratio of 40:1 peptide per 
BSA (Genosys, Woodlands. TX).
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A .
haptenation ratio 373:1
(TNP: KLH)NO
NO
B.
conjugation ratio 40:1 
(peptide:BSA)
ASESREECLEAHAEIISTNS
BSA
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Alternate Production o f  IHNV Glycoprotein Antigen
In order to assess the trout immune response to a single IHNV gp epitope, a 
20-mer peptide was synthesized (Genosys. Woodlands, TX) based on epitope analysis 
performed by Mourich and Leong (1991). These investigators mapped the immunogenic 
regions of the IHNV gp using trpE fusion proteins, containing various regions of the 
IHNV gp gene, expressed in Escherichia coli. Although multiple regions of the 
glycoprotein stimulated a response in the mouse, only one of the glycoprotein regions and 
more specifically the 20-mer peptide region located at gp amino acid residues 321 to 340 
(ASESREECLEAHAEIISTNS) stimulated a measurable antibody response in trout. This 
synthetic peptide was received Ivophilized (conjugated to BSA) and was reconstituted in 
PBS, pH 7.2. and filter sterilized (0.22 pm) prior to use for primary immunization of trout 
(Fig. 6B).
IHNV Purification
IHNV (Hagerman Valley isolate, strain 039-82) was obtained from Dr. Sandra 
Ristow of Washington State University and propagated in the chinook salmon embryo 
(CHSE-214; American Type Culture Collection ceil repository line CRL 181) cell line as 
described by Leong et al. (1981). In brief, CHSE cells were grown to confluency in
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tissue culture flasks in RPMI-1640 medium supplemented with L-glutamine, sodium 
bicarbonate. 10% fetal bovine serum (FBS: Life Technologies, Inc.) and antibiotics 
(penicillin 100 U ml'1, streptomycin 100 jig ml"1) (media and supplements from Sigma 
unless otherwise noted). Culture media was removed by pipetting and the monolayer 
coincubated with IHNV for one hour with gentle rocking on a platform (Bel-Art. 
Pequannock. NJ). After one hour the medium containing free virus was removed by 
pipetting and replaced with fresh RPMI medium supplemented as above, with 2% FBS. 
Cells were incubated at 17°C in ambient air conditions until the observed viral cytopathic 
effect (CPE) was 100%. To purify EHNV for subsequent use as an antigen, IHNV 
infected cells and supernatant were harvested and cellular debris removed by low speed 
centrifugation. The supernatant from this procedure was centrifuged in a Beckman SW 
28 rotor onto a glycerol cushion for 90 min at 90,000 x g. Virus pellets were resuspended 
in STE buffer, pH 7.0, and centrifuged through a discontinuous sucrose gradient 
comprised of 50%, 35%. and 20% sucrose layers (sucrose diluted in STE) as above. The 
purified virus was retrieved from the 20% and 35% sucrose interface after centrifugation. 
This layer was removed and transferred onto a continuous gradient of 5% to 35% sucrose 
in STE which was centrifuged to further purify the virus in a Beckman SW 41 rotor for 
30 min at 55,000 x g. The resultant purified virus was collected and the protein
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concentration was determined using a modified Lowry protein assay procedure and 
stored in aliquots at -80°C. Confirmation of the recovery/purity of IHNV was done by 
analysis on a 12% SDS-PAGE mini-slab gel (Bio-Rad, Hercules, CA) with comparison to 
an aliquot of previously purified virus.
Electrophoretically separated virus protein bands were visualized by silver stain 
using a commercial kit manufactured by Sigma. The virus was also titrated using a 
sandwich ELISA technique (Ristow et al. 1993) and an immunoblot performed to assess 
reactivity against a panel of IHNV monoclonal antibodies. Finally, the purified virus was 
formalin-killed and extensively dialvzed against PBS prior to use as an immunogen (for 
secondary immunization). Virus used as the coating antigen for ELISA was not 
formalin-killed.
Immunization and Sample Collection
Rainbow trout were anesthetized by immersion in 3-aminobenzoic acid ethyl ester 
(MS-222) (0.2 g I'1) and approximately 3 ml of blood was collected from the caudal vein 
in heparinized Vacutainer tubes (Becton-Dickinson, Franklin Lakes, NJ) at each time 
interval and tubes were immediately placed on ice to minimize ceil mortality. Primary 
immunization was performed by intraperitoneal (i.p.) injection with 100 pg TNP-KLH or
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EHNV gp peptide-BSA. or with PBS. pH 7.2. emulsified 1:1 in Freund’s complete 
adjuvant (FCA; Difco Laboratories. Detroit, MI). Antigen was injected in a final volume 
of 0.05 ml. Trout received a secondary immunization in the same manner (i.p.) with 
20 pig of antigen emulsified in Freund’s incomplete adjuvant (FIA; Difco) 25 weeks post 
primary injection in a final volume of 0.05 ml. The IHNV group received formalin-killed 
whole virus for the secondary immunization instead of the synthetic glycoprotein epitope 
injected for the primary immunization. Each fish was bled at week 0, 5, 10, and 20 post 
primary and week 10 post secondary immunization.
Immunoselection of Antigen-Specific B Cells
Peripheral blood leukocytes were isolated by a standard leukocyte isolation 
procedure (Kaattari et al. 1986). Briefly, whole blood was centrifuged at 500 x g for 15 
min at 4° C and the plasma removed and stored in aliquots at -80° C until analyzed. All 
subsequent centrifugations were also at 500 x g and 4° C. The cell pellet was resuspended 
in RPMI-1640 (Sigma)(l:8 dilution) and the suspension layered over an equal volume of 
Histopaque 1077 (Sigma). The cells were centrifuged for 45 min and the leukocytes 
collected from the interface above the Histopaque layer. These cells were washed an 
additional two times in RPMI-1640 for 10 min each and the final cell pellet resuspended
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in RPMI-1640. Viability of lymphocytes and cell count was determined by trypan blue 
exclusion.
Uncoated magnetic beads (DynaBeads M-450, Dvnal, Lake Success. NY) were 
coated with IHNV or TNP-BSA for immunomagnetic separation of specific B cells based 
on their surface receptor affinity for the specific coating antigen per the manufacturer's 
instructions. Beads were coated by the addition of 9-15 pg protein 100 pl‘l of beads 
suspended in 0 .1 M sodium phosphate buffer, pH 7.4. This suspension was incubated on 
an end-over-end tube rotator for 24 h at 4° C. Afterwards the unbound protein was 
removed by placing the tube into a Dynal magnetic particle concentrator (MPC) and 
aspirating the supernatant. The coated beads were washed three times in PBS containing 
0.1% BSA, pH 7.2. The first two washes were performed for 5 min each at 
4° C and the last wash was done overnight at 4° C.
A minimum ratio of 4 beads per lymphocyte was co-incubated at 4° C with end- 
over-end mixing and the bead-rosetted cells isolated by placing the test tube in the MPC 
for 2-3 minutes per manufacturer’s direction. The supernatant was removed by pipetting 
and antigen-specific cells were washed twice in PBS, pH 7.2, containing 0.1% BSA. The 
cells were detached by repeated pipetting of the rosetted beads and the magnetic beads 
removed with the MPC. Confirmation of recovery and quantitation of the cells was 
performed by trypan blue exclusion of the panned, flow-through, and bead fractions
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generated in this manner. Panned cells were examined microscopically to confirm the 
presence of surface Ig by labelling with a flourescent mAb (Warr’s L-14; DeLuca et al. 
1983) which recognizes an Fc epitope on the trout B cell receptor (BCR). Antigen- 
specific cells were then immediately processed for extraction of total RNA using TriZol 
(Life Technologies, Inc., Gaithersberg, MD) and the RNA was stored at -80° C until 
week 10 samples had been collected and individuals evidencing a shift in antibody 
affinity were identified.
Production and Sequencing of cDNA Clones
Total RNA from antigen-specific B cells was used as template for first strand 
synthesis of cDNA and subsequent RT-PCR (reverse transcriptase-polymerase chain 
reaction). All PCR reactions were performed in a MJ DNA Engine Peltier thermal cycler 
(MJ Research Inc.,Watertown, MA) using thin-walled 0.2 ml PCR tubes (individual or 8 
per strip) and a high fidelity Taq polymerase (PLATINUM Taq High Fidelity polymerase; 
Life Technologies, Inc.) to minimize the introduction of PCR artifact point mutations.
An anchor primer and a forward primer devised from the relatively invariant framework 
regions of the VH antibody gene (Hansen et al. 1994) were used to amplify the specific 
intervening CDR2 region of the trout by PCR. Hansen et al. designed these primers by 
aligning several amino acid and nucleotide sequences from various vertebrate VH genes
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to develop the following degenerate primers for V region genes: Sense FR2 = 5’- 
CCISAIMGNCCTGYAMAGCCTCYDDITT-3’ and antisense FR3 = 5 '- 
CCGGATCCGGACAITAATAA VNYGCNGTGTCYTC-3 ’. The FR3 primer was 
designed to take advantage of the fact that most VH genes end in the conserved amino 
acid motif YYCAR. Amplification of the expected PCR product, approximately 240 bp, 
was confirmed on a 1.2% agarose gel by standard DNA electrophoresis methods 
(Sambrook et al. 1989) and subsequently cloned into the TA cloning vector (Invitrogen, 
Carlsbad, CA). Clones containing the putative CDR2 insert were selected by blue/white 
screening on LB agar plates containing ampicillin (amp) and 5-bromo-4-chloro-3- 
indolyl-D-galactoside (X-gal) (per formulation in Sambrook et al. 1989). Plasmid DNA 
was isolated using a CONCERT plasmid DNA purification kit (Life Technologies, Inc.) 
and presence of insert confirmed by digestion with the restriction enzyme Eco RI 
(Promega, Madison, WI). Analysis of the digestion products was done on a 1.2% agarose 
gel as previously described. Plasmid preps shown to possess the appropriate size insert 
were sequenced using a NEN Global IR2 automated DNA Sequencer (LI-COR, Lincoln. 
NE) using a Thermo Sequenase™ cycle sequencing kit with 7-deaza-dGTP (Amersham 
Pharmacia Biotech Inc., Piscataway, NJ). Cycle sequencing reactions were set up 
employing a protocol provided by LI-COR utilizing 50 fmol of plasmid DNA template. 
Sequencing alignments were performed using MacVector v. 7 (Oxford Molecular Group,
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Molecular) format and BLAST sequence similarity searches (Altschul et al. 1997) were 
performed to confirm sequence identity with published trout Ig VH sequences (GenBank. 
National Center for Biotechnology Information. Bethesda, MD).
Additional sense primers were employed later in the study (Table IV) (generously 
provided by Dr. Greg Warr from the Medical University of South Carolina), used in 
combination with an antisense primer that annealed to sequence in the constant region 
( CHI = 5’- GGGAGCGGAGATATGATGA-3’) to ensure there was no skewing of 
selection of VH amplicons based on primer bias (Fig. 7). These PCR products (insert 
range -245 - 450 bp) were cloned and sequenced as described above.
Genomic DNA Isolation
Extraction of genomic DNA (gDNA) was performed as described by Spruell et al. 
(1994) for fin clip samples, otherwise routine genomic isolation using trout RBCs was 
done per Sambrook et al. (1989). Briefly, fin clip samples approximately 0.7 c n r were 
excised and stored at -80°C in 95% (v/v) ethanol until processed. Samples were 
incubated in digestion buffer for 4 - 5 h in a 55°C waterbath with gentle shaking. An 
equal volume of phenolrchloroform: isoamyl alcohol (PCI) (25:24:1) was added and the 
sample mixed gently by inversion. The aqueous layer containing DNA was recovered by
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Table IV. Sequence of primers provided by Dr. G. W. Warr (Medical University 
of South Carolina).
Primer Sequence
G-843 ACTGACATGTGCCTGTAGTGGAWT
G-844 ACTGTCMTGTACTGTGTMTGGWTT
G-845 CATCTCCTGCAAATTCTCTGGGTT
G-847 TCTGTACMRCYTCTGGSTTCACATT
G-848 ACCATCTCYTGTAAGGTYTCATAT
G-849 TCTCTCCTGTAAGRKATCTGGRTA
G-850 TCAGTGAAACTATCTTGCCAAGTC
G-851 ACT G ACCTGT ACTT ATG ATGG AAT
G-852 ATTGTCATGTAAAATCTCTGGGTT
G-853 TCTGAGCATCACCTGTAAGGTC
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Figure 7. PCR Primer Strategy. A suite of primers was employed to amplify trout Ig VH 
cDNA sequence encompassing VH gene encoding the FR1 (partial), CDR1, FR2, and 
CDR2. In some instances a 3’ primer was utilized with various FRl primers which 
allowed for the amplification of FRl (partial), CDR1, FR2, CDR2, FR3, CDR3, FR4, and 
into the Cp 1 domain. 5’ primers G-843 - G-853 were designed by Dr. G. W. Warr 
(Medical University of South Carolina) and FRl was designed by Hansen et al. 1994.
The constant region primers CH1-CH3 were designed in our laboratory by Dr. A. 
Dacanay.
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centrifugation of the samples for 15 min at 12,000 x g and extracted a second time with 
chloroform: isoamyl alcohol (24:1). Genomic DNA was precipitated by the addition of 
0.1 vol 3 M ammonium acetate. pH 5.2, and 2.5 vol of 100% ethanol and then collected 
by spooling on sterile glass rods. The DNA was washed with 70% ethanol and dialvzed 
at 4°C with three buffer exchanges of Tris-NaCl-EDTA (STE) buffer, pH 8.0, in 3500 
MWCO dialysis tubing (Spectrum Laboratories, Houston, TX). This step was included 
to remove residual contamination from the samples prior to restriction enzyme digestion 
and assayed for purity spectrophotometrically ( A ^ A ^  > 1.6). Integrity of high 
molecular weight gDNA was examined by electrophoresis on a 0.8% agarose gel.
VH Gene Identification
Probe Construction and Southern Blotting
To determine the copy number of Cp genes in the trout genomic DNA, an 
additional set of primers was designed (sense CH2 = 5’- CATCAACTGCTCCGACTTT 
GTTC-3' and antisense CH3 = 5'-CGCCTCGTCATTCCATTTG-3') and used to generate 
a plasmid construct containing a 130 bp insert that would be used in experiments 
described below. Probes based on cDNA sequences diagnostic for individual VH gene 
families and the Cp gene were produced by labeling via random priming in the presence 
of [a-‘3P] dATP (NEN Life Science Products, Boston, MA) and used to screen genomic
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DNA using a standard Southern blot technique (Sambrook et al. 1989). Briefly, 10 pg 
2DNA from individual trout were digested with Eco RI restriction endonuclease and then 
eiectrophoresed on 0.8% agarose gels. A DNA molecular weight marker (1 Kb DNA 
ladder. Life Technologies, Inc.) was aiso run on the gel. The gel run was considered 
complete once the first loading buffer dye front (bromphenol blue) had run to the end of 
the gel. The lane containing the molecular weight ladder was removed and stained with 
ethidium bromide for visualization via UV transillumination of the migration of the 
individual bands to provide a calibration curve. Gels were subjected to two denaturation 
washes and two neutralization washes (20 min each at room temperature on an orbital 
shaker) and then equilibrated in lOx SSC which was used as the transfer buffer to blot the 
gel onto a 0.45 pm pore sized nylon membrane (MagnaGraph, Osmonics Inc., 
Minnetonka, MN) by capillary transfer. The DNA was fixed to the membrane by 
exposure to 120,000 pJ of UV energy (UV Stratalinker 1800, Stratagene, La Jolla, CA). 
To hybridize the probe to the membrane, the probe was first denatured by incubation at 
95° C then added to PerfectHyb Plus (Sigma) hybridization buffer which co-incubated 
with the blotted membrane overnight in hybridization bottles at 68° C in a waterbath with 
a rotissier. Low stringency (at room temperature) and high stringency (at 68° C) washes 
were performed. The membrane was wrapped in clear plastic and exposed to Kodak 
Biomax MS film (Fisher Scientific) with an intensifying screen at -70° C for 5 days
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before development using a Konica SRX-I01 medical film processor (Konica 
Corporation, Tokyo, JPN).
Gene Titration
Plasmid and genomic DNA concentrations were determined fluorometrically 
(DynaQuant, Hoefer Scientific Instruments, San Francisco, CA). The DNA per haploid 
genome per trout erythrocyte has been calculated to be 2.4 pg (Ohno and Atkin, 1966), 
thus 10 pg of trout DNA contains 4.26 x 106 haploid genomes. This number of Eco RI 
linearized plasmids was loaded onto a 0.8% agarose gel to yield one genome equivalent 
(GE) and multiples of this number were loaded to provide a range of genomic equivalents 
(GE = 1,3,5,10 for Cpl probe)(GE = 1, 5,10, 15, 20, 30, 40, 50 for VH family probes). 
Blots were developed as described above and the relative densitometry of the bands was 
assessed for the number of VH or Cp gene copies present.
Determination of Antibody Titers and Affinity
Specific Antibody Titration
The titration of specific anti-IHNV gp or TNP antibody in the plasma was 
determined by an antigen-capture enzyme-linked immunosorbent assay as previously 
described (Ristow et al. 1993; Shapiro et al. 1996). Briefly, wells of a 96-well microtiter
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plate were coated overnight at 4°C with 50 pi w e l l o f  2 pg m l 1 antigen (TNP-BSA or 
IHNV) in coating buffer. Afterwards, the unbound protein was washed from the plate by 
washing three times with Tris-buffered saline with 0.1% Tween 20 (TTBS). The wells 
were blocked with 200 pi well ‘‘ TTBS containing 1% bovine serum albumin (BSA: 
Sigma) for one h at room temperature in a humidified chamber. The wells were washed 
again with TTBS three times and serial dilutions of the plasma samples added (50 pi 
well !). For anti-TNP, dilutions were made in TTBS containing 1% BSA ranging from 
1:25 to 1:1353125 using a five-fold serial dilution scheme. For anti-IHNV, dilutions 
were made in TTBS containing 1% BSA ranging from 1:30 to 1:14580 using a three-fold 
serial dilution scheme. The plate was incubated again at room temperature for one h as 
described above and then washed three times. Fifty pi well 1 of a 1 mg m l1 biotinylated 
mouse anti-trout Ig mAb (Warr's 1-14; de Luca et al. 1983) diluted 1:1000 in TTBS was 
added to each well and the plate was incubated and washed as above. Strepavidin- 
horseradish peroxidase (SA-HRPO; Sigma) was added to the wells in the same volume as 
above, using a 1:1000 dilution of 125 pg ml'1 SA-HRPO. After a final one h incubation 
the plate was washed and 50 pi well ' l of ABTS (2,2’-azino-bis(3-ethylbenz-thiazoline-6- 
sulfonic acid) developer solution (Sigma). The plate was covered with foil for 15-20 
min to allow chromogen development, then the optical density at 405 nm (ODjoj) was 
measured using a Titertek Multiskan MCC/340 microplate reader (Titertek, Chantilly,
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VA). The volume of plasma equivalent to one unit of antibody activity (defined as the 
amount of antibody required to produce a color intensity of half the maximum OD) was 
determined from a plot of O D ^  versus plasma volume (Arkoosh and Kaattari 1990).
TNP Affinity ELISA
Briefly, for the anti-TNP affinity measurements graded concentrations of the 
antigen TNP-BSA were coated onto an ELISA microtiter plate. To each well, a constant 
concentration of antibody activity (one unit - defined above) was added together with 
graded concentrations of the hapten inhibitor TNP-L-lysine (ICN Biochemicals. 
Cleveland, OH). The lowest coating antigen concentration captures the highest affinity 
antibodies within the volume of serum containing a standard unit of antibody activity and 
the simultaneous inhibition analysis using varying concentrations of hapten at each 
coating concentration provides an estimate o f K (Keq or aK) of that antibody 
subpopulation (Fig. 8). Therefore, the affinity of each of these subpopulations is defined 
by the equation:
K = - log(l/[H]J0)
where K is the affinity constant or the measure of the degree of binding between an 
antibody and its specific antigen and H*, is the concentration of hapten (TNP-lysine) 
required to cause 50% inhibition of the maximum OD for that coating concentration
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Figure 8. Schematic of anti-TNP affinity ELISA plate set-up. The coating antigen 
(TNP-BSA) is added to the plate in graded concentrations with the lowest concentration 
in row B, with 1:3 dilutions of antigen in increasing concentrations loaded from row B to 
row A. Row A is coated with coating buffer without antigen. Graded concentrations of 
the inhibitor, TNP-lysine, in TTBS containing 1% BSA is added with the lowest 
concentration in columns 3,4 and 1:5 serial dilutions added in duplicate to the other 
columns such that the highest concentration of inhibitor is in columns 11,12. No 
inhibitor is added to columns 1,2 (diluent buffer without inhibitor was added). After the 
inhibitor is added the plasma sample is added at 2 units specific anti-TNP activity per 
well, also diluted in TTBS containing 1% BSA. The graded green circles illustrate a 
representative affinity response.
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(Shapiro et al. 1996: Nieto et al. 1984). A weighted average affinity of all the antibody 
subpopulations was then calculated from the K values and the proportion of antibody in 
each subpopulation using the equation:
weighted average affinity = K x P 
where P = fraction of antibodies in the mixture which possess a particular K value (Nieto 
et al. 1984). Using a Microsoft Excel software macro, the affinity and proportion of 
antibody in each subpopulation as well as the weighted average affinity (aK) for a 
complex mixture of antibodies was easily obtained. The subpopulation distribution for 
each antiserum was plotted using DeltaGraph 4.5 (SPSS Inc., Chicago, IL) with the aK 
values along the abscissa (x-axis) and proportion of antibodies within the sub-population 
on the ordinate (y-axis).
Diethylamine Shift Assay
The affinity of the antibodies produced to the EHNV gp was determined using a 
solid phase assay that employs diethylamine (DEA; Sigma) as a denaturant which 
decreases the binding of lower affinity virus-specific antibodies (Thomas and Morgan- 
Capner 1991). Using the DEA ELISA method, assay plates were coated with EHNV as 
described for the antibody titration ELISA and all other steps of the assay were 
the same, excluding the dilution of samples (Fig. 9). In the DEA denaturant method,
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 9. Schematic of DEA shift ELISA plate set-up. The plate is coated with a 
uniform concentration of antigen and then plasma is serially diluted in TTBS containing 
1% BSA (indicated in odd numbered columns) or TTBS containing 1% BSA and 35 mM 
DEA. As indicated by graded green circles, a sample with low affinity antibodies is 
inhibited from binding the coating antigen in the presence of DEA. Plasma possessing 
high affinity / avidity antibodies will still react with the antigen coated on the plate in the 
presence of 35 mM DEA in buffer.
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three-fold dilutions of plasma were made in TTBS containing 1% BSA with and without 
35 mM DEA to yield a dilution range of 1:30 to 1:14580). The plasma dilutions were 
incubated for 2 h at room temperature in a humidified chamber. Once the ABTS 
developer was added and plates read at O D ^, two dilution curves were plotted for each 
sample: one for the plasma diluted in TTBS containing \%  BSA without DEA and one 
for the plasma diluted in TTBS containing 1% BSA and 35 mM DEA. Plasma antibodies 
which were not inhibited in the presence of DEA for binding the coating Ag compared to 
their non-DEA diluted counterpart possessed higher affinity for the coating antigen.
Immunopurification of Antibodies 
T.\P-Specific Antibodies
Immunoadsorbents for the affinity purification of the trout antibodies consist of 
CNBr-activated Sepharose beads conjugated with either TNP-BSA or TNP-lysine as per 
the manufacturer’s instructions (Sigma). Prior to immunoadsorption of the antibodies, 
plasma was diluted 1:2 in PBS, pH 7.2 and added to a slurry of coupled beads placed in 
Bio-Spin columns (Bio-Rad). The suspension was mixed overnight at 4° C and then anti- 
TNP antibodies were eluted using modified procedures of Harlow and Lane (1988). 
Non-adsorbed material wass eluted from the column using PBS until the OD^,, was 
equivalent to background. TNP-lysine (ImM) in PBS was added to the column and
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allowed to mix for 2 hr at 4°C on an end-over-end mixer (Lab Industries Inc.. Berkeley. 
CA). One column volume of eluate was collected and this step was repeated 3 times 
with the last mixing step occurring overnight at 4° C. Acid and base elutions were 
performed respectively with a single 2 hr mixing step prior to each fraction collection. 
One hundred percent recovery of the anti-TNP activity from each sample was achieved.
IHNV-Specific Antibodies
Anti-viral antibodies were purified from immune trout plasma by 
immunoprecipitation. Purified virus was added to 75 pi of each serum in 10 pg aliquots 
and gently stirred with a pipette tip. This suspension was incubated for an additional 5 
minutes at 17° C with gentle agitation on a rotary shaker. A total of 200 - 300 pg of virus 
was added to the plasma. The precipitate was isolated by centrifugation at 12,000 x g for 
5 minutes, gently washed once with PBS and isolated by centrifugation as before. The 
adsorbed antibody was isolated from the precipitate by vigorous resuspension of the 
precipitate in 100 pi of 100 mM glycine. pH 2.5. Antibody was further dissociated by 
incubating the precipitate in the glycine for 20 minutes at 17° C with agitation on a rotary 
table (300 rpm). The volume was increased to 400 pi with PBS and the viral proteins 
were removed by centrifugation at 130,000 x g for 90 minutes at 4° C. The solution was 
dialyzed against three exchanges of PBS in 12-14000 MWCO dialysis tubing (Spectrum
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Laboratories). Confirmation of binding specificity was conducted by determining that 
whole, isoelectrically-focused antibodies bound LHNV gp by Western blot analysis (after 
Hariow and Lane 1988).
IEF/2D-SDS PAGE Analysis of Antibodies
Whole plasma samples or immunopurified antibodies from plasma evidencing a 
shift to higher affinity specific antibodies were subjected to 2-dimensional EEF 
electrophoresis in an attempt to isolate putative newly emergent antigen-specific heavy 
chains in these samples compared to those from week 0 or week 5 not possessing unique 
isoelectropherotypes in similar studies performed in the laboratory. Quantitative 
densitometry of the focused H chains with an Alpha Imager 2000 Documentation and 
Analysis System was performed using Alpha Imager version 4.0 software (Alpha 
Innotech Corp., San Leandro, CA). Briefly, 5 pg of individual samples were subjected to 
isoelectric focusing per Harlow and Lane (1988) using a Hoefer Mighty Small tube IEF 
electrophoresis system per manufacturer's protocol (Amersham Pharmacia Biotech Inc.) 
for the first dimension electrophoresis (to separate by pi) and the Bio-Rad mini-Protean 
electrophoresis system for the second dimension (to separate by molecular weight). 
Visualization of 2-D protein spots was done by silver staining the second dimension 
acrylamide gels (Sigma silver stain kit) which also had a molecular weight marker well in
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which 3 jig of purified trout antibody or pi markers (Sigma) were electrophoresed for
comparison.
Variability Analysis
Ig VH cDNA sequence was obtained as described above using a variety of 
primers. If the sequence amplified by these primers included CDR3 or CH sequence, the 
sequence was truncated for variability analysis. Additional amino acid sequences were 
obtained from the Kabat database (Johnson et al. 2000) or the GenBank database (NCBI. 
Bethesda, MD) for analysis of amino acid variability. All Kabat database sequences were 
obtained from the July 2000 dataset using the variability search tool available at 
http://immuno.bme.nwu.edu/variabilitv.html. Per Wu and Kabat (1970), variability was 
determined by dividing the total number of different amino acids that occur at a single 
position of the Ig VH sequence by the frequency of occurrence of the most common 
amino acid at that position. The results were plotted as a histogram with amino acid 
position along the abscissa (x-axis) and variability on the ordinate (y-axis) using 
DeltaGraph 4.5.
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N-Terminal Sequencing o f Specific Antibody Heavy Chains
For protein sequencing, the second dimension gel (from above) was transblotted 
onto an Immobilon-P (Millipore. Bedford, MA) transfer membrane using the Bio-Rad 
mini-Protean II transblot apparatus (Bio-Rad). The membrane blot was stained with 
0.1% Coomassie brilliant blue R-250 in 50% methanol (v/v) which had been diluted in 
ultrapure water. The membrane was destained with a 50% methanol-10% acetic acid- 
40% ultrapure water solution which allowed the visualization of the stained protein 
“spots”. The membrane was equilibrated in ultrapure water and air-dried. Isolated heavy 
chain proteins determined to be unique to the plasma samples collected late in the 
specific immune response were excised and sent to the Louisiana State University 
Medical Center protein sequencing facility (New Orleans, LA) for N-terminal 
sequencing. Based on analysis of existing Genbank database sequences, five to fourteen 
amino acid residues require sequencing to prove diagnostic in terms of trout VH gene 
family usage (Zhang 1999). This sequence analysis was performed to provide additional 
support that the family specific sequences we might identify in our cDNA analyses would 
be the ones being used to produce the newly emergent higher affinity antibodies post­
immunization.
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RESULTS
Trout Antibody Response to the Defined Hapten TNP
Serological Analyses 
Antibody Titers / Affinity
Anti-TNP antibody titers of rainbow trout immunized with TNP-KLH were 
measured using standard ELISA techniques. In the TNP-KLH immunized group, ail 
animals developed an antibody response to the hapten (ranging from 0.5 to 3 units 
activity pi'1 at weekO to 237 to 940 units activity pi '1 plasma by week 10) (Fig. 10) and 
the control samples did not develop positive titers to TNP or IHNV (all samples < 3 units 
activity pi'1. A comparison of week 5 and week 10 affinity ELISA aK profiles allowed 
identification of the two trout (#9 and #10) with the highest affinity subpopulation shifts 
as measured by the change in the weighted average aK and the development of 
populations with uniquely high aK's at the later timepoint. The weighted average aK at 
week 5 was 4.77,4.45, 5.36, 4.59, and 4.62 for trout #  6-10, respectively and increased 
by week 10 to 5.46, 5.22, 5.41, 5.18, and 5.3, respectively. Individual aK profiles for the 
two time points are provided in figure 11. Upon secondary immunization with TNP- 
KLH trout #9 was shown to possess additional newly emergent subpopulations of higher 
affinity antibodies (Fig. 12) and, thus, this individual was selected for the molecular 
analysis of the antibody response. Affinity ELISA measurements of trout #10 week 35
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Figure 10. Anti-TNP titers. Graph of anti-TNP titers of individual trout immunized with 
TNP-KLH at weeks 0, 5, and 10. The x-axis denotes the time point of sample collection 
(week 0, 5, 10) and the y-axis denotes the units of specific anti-TNP antibody activity pi'1 
plasma.
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Figure 11. Affinity profiles of anti-TNP plasma for individual trout. These profiles 
illustrate affinity shifts between week 5 (blue bars) and week 10 (green bars) for five 
trout (#6 - #10). The aK range of each histogram is denoted on the x-axis and percent of 
total antibody represented by that affinity subpopulation is given on the y-axis.
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Figure 12. Affinity profile of anti-TNP plasma from trout #9. This profile illustrates a 
shift in affinity subpopulations at week 5 (blue), 10 (green), 20 (red), and 35 (yellow). 
The aK range of each subpopulation is depicted on the x-axis, the percent of the antibody 
pool possessing that affinity on the y-axis, and time post-immunization on the z-axis.
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plasma did not provide a definitive measure of aK, although the assay was repeated, thus 
a measure of the secondary TNP response (e.g. week 35) for this individual was not 
obtained (Fig. 13).
IEF of TNP-Specific H Chains
Trout antibody against TNP was purified by adsorbing plasma from  TNP 
immunized trout on an affinity column containing TNP-coupled Sepharose as described 
in the Methods section (Fig. 14). The primary purpose of purification was to isolate 
samples for N-terminal sequencing of TNP-specific heavy chains (see section below). 
Antibody purification also allowed for easy reference of trout antibody heavy and light 
chains during the 2D-IEF/SDS-PAGE analysis of non-purified trout plasma samples 
when purified Ab was included on the gel as a molecular weight marker.
Once plasma samples had been collected from all time points, 2D-IEF/SDS-PAGE was 
performed which revealed newly emergent heavy (and light) chain proteins from the trout 
which underwent an antibody affinity shift. Trout #9 2D antibody profiles (Fig. 15) from 
week 5, 20 and 35 reveal the presence of new heavy chain isoelectrophereotypes which 
accumulate temporally over the course of the immune response. Densitometric analysis 
of the week 5 sample is characterized by heavy chain pis of 5, 5.4 - 5.6. and another 
single spot at 6.2 (Fig. 16A). By week 20 the profile shifts with new isoelectropherotypes
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Figure 13. Affinity profile of anti-TNP plasma from trout #10. This profile illustrates a 
shift in affinity sub-populations between week 5 (blue) and week 10 (green) and 
illustrates the accumulation of new, increased affinity sub-populations through week 20 
(red). The aK range of each subpopulation is depicted on the x-axis, the percent of the 
antibody pool possessing that affinity on the y-axis, and time post-immunization on the 
z-axis.
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Figure 14. Purified trout antibody protein profile for trout #9. Silver stained 12% 
SDS-PAGE gel illustrating the protein profile (A) before and (B) after affinity 
chromatography purification of trout plasma. Molecular weight markers are indicated 
the far left lane.
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Figure 15. Two dimensional IEF / SDS-PAGE gels of plasma from trout #9 which 
was immunized with TNP-KLH emulsified in Freunds complete adjuvant and shown to 
possess increased anti-TNP affinity over the course of the experiment as measured by 
affinity ELISA. (A) Five pg of plasma from week 5 run out on a gel and silver stained. 
(B) An equivalent amount of plasma from week 20 and (C) week 35 reveals a heavy 
chain protein profile possessing new H chain isoelectropherotypes compared to the 
earlier profile (indicated by circles). Purified trout antibody (H chain 72 kD, L chain 25 
kD) is included on the gels as a molecular weight marker.
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Figure 16. Densitometric profile of silver stained 2D IEF / SDS-PAGE gels at 72 kD.
(A) Profile of anti-TNP trout #9 plasma week 5. (B) Profile for same trout at week 20 
and (C) week 35. This trout did evidence a shift in antibody affinity profiles as measured 
by affinity ELISA which correlates to the emergence of new H chain 
isoelectropherotypes. The x-axis represents the pi range and the y-axis denotes optical 
density (OD).
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at 5.1 - 5.3 and a loss of the heavy chain protein spot of pi 6.2 (Fig. 16B). Week 35 
plasma which corresponds to the secondary antibody profile in trout # 9 revealed the 
emergence of even more new IEF spectrotypes, with these new heavy chains possessing 
pis in the range of 5.7 - 5.8 and 6 .1 - 6.3 (Fig. 16C). As all fish in the TNP immunized 
group evidenced an antibody affinity shift, plasma samples from a TNP-KLH immunized 
trout that developed a TNP titer without undergoing an affinity shift was included in the 
2D-EEF/SDS-PAGE analyses (from Zhang 1999). The sample for trout #918 did not 
evidence a change in heavy chain isoelectropherotypes between week 5 and week 20 
(Fig. 17 - 18), and neither did the profile for the PBS control trout #1 (Fig. 19 - 20). This 
lack of profile change within non-affinity shift trout samples emphasizes that 
immunization of these animals with adjuvant was not sufficient to elicit any measurable 
change in the antibody heavy chain composition.
Molecular Analyses
Panning for TNP-Specific B Cells
At each sampling time point, peripheral blood lymphocytes were isolated, or 
"panned", so temporal changes in VH gene sequence could be monitored. This process 
w as accomplished by co-incubation of peripheral blood leukocytes with TNP-BSA 
conjugated magnetic beads in the presence of saturating concentrations of BSA in PBS.
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Figure 17. Two dimensional IEF / SDS-PAGE gels of plasma from trout #918 that 
was immunized with TNP-KLH emulsified in Freunds complete adjuvant and did not 
evidence an antibody affinity shift over the course of the experiment as measured by 
affinity ELISA. (A) Five jig of plasma from week 5 run out on a gel and silver stained.
(B) An equivalent amount of plasma from week 20 reveals a heavy chain protein profile 
which is unchanged relative to the earlier profile. Purified trout antibody is included 
on the gels as a molecular weight marker, of which only the H chain (72 kD) is visible.
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Figure 18. Densitometric profile of silver stained 2D IEF / SDS-PAGE gels at 72 kD.
(A) Profile of anti-TNP trout #918 plasma week 5. (B) Profile for same trout at week 20. 
This trout did not evidence a shift in antibody affinity as measured by affinity ELISA.
The x-axis represents the pi range and the y-axis denotes optical density (OD).
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Figure 19. Two dimensional EEF / SDS-PAGE gels of plasma from trout #1 immunized 
with PBS emulsified in Freunds complete adjuvant. A. Five pg of plasma from week 5 
run out on a gel and silver stained. B. An equivalent amount of plasma from week 20 
reveals a heavy chain protein profile which is unchanged compared to the earlier profile. 
Purified trout antibody was included on the gels as a molecular weight marker, of which 
only the H chain is visible.
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Figure 20. Densitometric profile of silver stained 2D IEF / SDS-PAGE gels at 72 kD. 
(A) Profile of PBS control trout # 1 plasma week 5. (B) Profile for same trout at week 
20. The x-axis represents the pi range and the y-axis denotes optical density (OD).
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These adherent lymphocytes were detached from the beads via physical disruption by 
repeated pipetting. Both adherent (Fig. 21 A) and non-adherent lymphocytes (Fig. 2 IB) 
were stained with FLIC conjugated TNP-BSA to determine their antigen specificity using 
fluorescent light microscopy (40x). As can be seen, virtually 100% of the panned 
lymphocytes recognize TNP. whereas 100% of the non-adherent cells do not recognize 
the hapten. Similar results were seen when panning with IHNV-coated beads.
Typically, 3 ml of heparinized. whole blood yielded approximately 10s leukocytes at each 
sampling. After panning, approximately 0.5 -1 x 106 antigen-specific cells were 
recovered for isolation of total RNA.
cDNA Sequences
Primers which successfully amplified TNP-specific template were all family V 
specific (Table V) and there was one primer pair, capable of amplifying family I and 
family V homologous sequence, which also amplified TNP-specific template but the 
sequence itself was a family V sequence. The deduced amino acid sequence of TNP- 
specific cDNA (using the Mac Vector protein translation tool) revealed replacement 
mutations which accrued in the majority of clone sequences from week 10 through week 
35 (Table VI) occurring primarily in CDR2. Three replacement mutations were observed 
to occur in FR, lie 37-> Val37 in FR2, Thr48 -> Val 48, and IIe81-» Ser81 in FR3.
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Figure 21. Immunofluorescence demonstrating efficiency of immunobead purification of 
antigen-specific trout lymphocytes. Peripheral blood lymphocytes were ‘panned’ using 
TNP-BS A conjugated beads in the presence of saturating concentrations of BSA. These 
lymphocytes, detached from the beads (A), and the non-adherent lymphocytes (B) were 
stained with FITC conjugated TNP-BSA (40x). As can be seen, virtually 100% of the 
panned lymphocytes recognize TNP, whereas 100% of the non-adherent cells do not 
recognize the hapten. Similar results were seen when panning with IHNV-coated beads.
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Table V. Primers which amplified TNP-specific trout Ig cDNA.
primer i.d.
most homologous 
BLAST specificity
amplify Ag-specific 
template?
G-843/CH1 family V -
G-844/CH1 family IX -
G-845/CH1 family VIII, III -
G-847/CH1 family V -
G-848/CH1 family V, I -
G-849/CH1 family V + TNP
G-850/CH1 family VII -
G-851/CH1 family V + TNP
G-852/CH1 family IV -
G-853/CH1 family VIII -
FR1/FR3 family V + TNP
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Table VI. Representative TNP-specific VH cDNA from trout #9 and controls - deduced amino aeid translations.
FR1 CDR1 FR2 CDR2 FR3
gDNA TCTASEFTFSSYYMAWIRQAP6KGLEWTASSYSTAT— YY SQSVQGRFTISRDDSRSKLYLQMNILKSEDTAPYYCAR
Trout #9
wk 0 TCTASEFTFSSYYMAWIRQAPGKGLEWTASSYSTAT--YYSQSVQGRFTISRDDSRSKLYLQMNILKSEDTAPYYCAR
w k5 TCTASEFTFSSYAMAWIRQAPGKGLEWTASSYSTST— YYSQSVQGRFTISRDDSRSKLYLQMNILKSEDTAPYYCAR
Wk 10 TCTASEFTFSSYYMAWVRQAPGKGLEWIAYISSASTSIYYSQSVQGRFTISRDDSRSKLYLQMNILKSEDTAPYYCAR 
Wk 20 TCTASEFTFS S YYMAWVRQAPGKGLEWI A YIS^ASTPI YYSQSVQGRFT ISRODSRSKLYLQHNSLKSEDTAP YYCAR 
wk 35 TCTASEFTFS SYYMAWVRQAPGKGLEWIAYIS -ASTPI YYSQSVQGRFT ISRDDSRSKLYLQMNSLKSEDTAP YYCAR
PBS Controls
TCTASEFTFSS YYMAWI RQAPGKGLE WTASS YSTAT - - YY SQSVQGRFTI SRDDSRSKLYLQMNI LKSE DTAP YYCAR
Table VII. TNP-Specific VH cDNA from #9 highlighting mutations. Consensus 
sequences are denoted by an asterisk (*). Replacement mutations are indicated by a red 
nucleotide. Replacement mutations that occur to sequence previously mutated are 
indicated in blue. The majority of sequences after wk 5 accrued replacement mutations 
in CDR2. Additionally, there were three mutations which became fixed in FR sequences 
later in the response (wk 10+:Ile 37—»Val 37,Thr 48—* lie 48; wk 20+ ; lie 81-+ Ser 81).
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wk 0 A C C T G C A C C G C C T C C G A G T T C A C A T T C A G C A G C T A C T A C A T G G C G T G G A T
( n = 1 0 ) * * * * * * *
CAGACAGGCTCCTGGGAAAGGACTGGAGTGGACCC-CTTCTAGTTATAGTA
CTGCTACATATTATTCCCAGTCAGTCCAGGGTAGATTTACCATCTCCAGA
GATGACTCAAGATCTAAGCTGTA.CC TACAGATGAACATTCTGAAGTCGGA
GGACACCGCGCCTTATTACTGTGCGAGA
wk 5 ACCTGCACCGCCTCCGAGTTCACATTCAGCAGCTACTACATGGCGTGGAT  
 ^ 1 0 )
CAGACAGGCTCCTGGGAAAGGACTGGAGTGGACCGCTTCTAGTTATAGTA
CTGCTACATATTATTCCCAGTCAGTCCAGGGTAGATTTACCATCTCCAGA
GATGACTCAAGATCTAAGCTGTACCTACAGATGAACATTCTGAAGTCGGA
GGACACCGCGCCTTATTACTGTGCGAGA
wk 10 ACCTGCACCGCCTCCGAGTTCACATTCAGCAGCTACTACATGGCGTGGAT  
( n = 1 0  ) ★
CAGACAGGCTCCTGGGAAAGGACTGGAGTGGACCGCTTCTAGTTATAGTA
CTGCTAC-------------- ATATTATTCCCAGTCAGTCCAGGGTAGATTTACCATC
* * ^  ■*'*■*■ ★ ATCTAT
TCCAGAGATGACTCAAGATCTAAGCTGTACCTACAGATGAACATTCTGAA  
GTCGGAGGACACCGCGCCTTATTACTGTGCGAGA
★  ★ ★ ★ ★ ★ ★ ★ ★ ■ H r  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ i t  ★ ★ ★ ★ ★ ★ ★ ★ *
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wk 20 A C C T G C A C C G C C T C C G A G T T C A C A T T C A G C A G C T A C T A C A T G G C G T G G A T
( n = 9 )  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * G *
CAGACAGGCTCCTGGGAAAGGACTGGAGTGGACCGCTTCTAGTTATAGTA  
„ * * * , * * , * * * * * * * * * * * * * * * * * *  ------
CTG CTAC-------------- ATATTATTCCCAGTCAGTCCAGGGTAGATTTACCATC
*  *  i t  Q ^ C T A T  - i t * - * '* : - * - * '* - * - '* '* * - * - *  - r w - j r - w w - w w * * - * -
TCCAGAGATGACTCAAGATCTAAGCTGTACCTACAGATGAACATTCTGAA  
,*»»***»*,****************»***************TC******
GTCGGAGGACACCGCGCCTTATTACTGTGCGAGA
wk 35 ACCTGCACCGCCTCCGAGTTCACATTCAGCAGCTACTACATGGCGTGGAT  
( n = 3 ) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * G *
CAGACAGGCTCCTGGGAAAGGACTGGAGTGGACCGCTTCTAGTTATAGTA
CT G C T A C --------------ATATTATTCCCAGTCAGTCCAGGGTAGATTTACCATC
TCCAGAGATGACTCAAGATCTAAGCTGTACCTACAGATGAACATTCTGAA
GTCGGAGGACACCGCGCCTTATTACTGTGCGAGA
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Residue 37 is adjacent to the highly conserved Trp 35 which, by definition, demarcates 
the boundary between CDR1 and FR2. Residue 48 is also located on the boundary 
between FR2 and CDR. Residue 81 is a known intrinsic (non-Ag selected) mutational 
hotspot in mammals and this appears to hold true with fish antibodies (reviewed in 
Miistein and Neuberger 1996). There were two separate sets of insertions/deletions 
observed to occur in CDR2. as well as mutation of Ser 5 1 —» lie 51. Residue 51 has not 
been described as a mutational hotspot in mammalian H chains, thus mutation noted at 
this position may be considered extrinsic. Although point mutations were observed to 
occur in a temporal fashion in the majority of sequences from trout #9 (the trout with the 
highest TNP antibody affinity shift) (Table VII), sequences derived from PBS control and 
naive trout cDNA samples did not possess any replacement mutations and few silent 
mutations compared to #9 sequences.
Over the course of the anti-TNP response the utility of the Hansen et al. (1994) 
primers became limited in the ability to amplify sequence. This may be indicative of an 
additional shift in the response which we were not able to address as none of the primers 
we were using amplified sequence from the majority of template available from this time 
point. It is still questionable as to whether we have primers capable of amplifying cDNA 
for all trout Ig VH (Table VIII).
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Table VIII. Primers which amplified non-antigen selected trout Ig cDNA.
prim er i.d.
most homologous 
BLAST specificity
G-843/CH1 family V +
G-844/CH1 family IX -
G-845/CH1 family VIII, HI +
G-847/CH1 family V
G-848/CH1 family V, I -
G-849/CH1 family V +
G-850/CH1 family VH -
G-851/CH1 family V +
G-852/CH1 family IV +
G-853/CH1 family VIII +
FR1/FR3 family V, I +
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Additional cDNA sequences were also obtained for trout #10 and support the 
observation that replacement mutations also occurred in the other trout that underwent a 
significant TNP antibody affinity shift during the primary antibody response against TNP 
(Appendix II).
PCR amplification of cDNA produced from non-antigen selected RNA template 
produced amplicons which, when cloned, represented the majority of trout Ig VH 
families (Table VTII). However, no representatives of Ig VH family II. VII, IX or X were 
ever amplified in this study. Of these, only family VII is represented by a single 
reference sequence in GenBank (accession number L28747) and the others are 
represented by two to four reference sequences each (family II, accession numbers 
X65262. X81512. X81509: family IX, X81505,X81504,X81507,X 81506; family X. 
X81508, X81489) all of which were identified in European stocks of rainbow trout (Lee 
et al. 1993; Andersson and Matsunaga 1995). This was an unexpected result as it was 
anticipated that without selection, members from all trout Ig VH families would be 
amplified to some degree.
VH Gene Utilization and Gene Titration
Based on our cDNA studies, Family V appears to be used to generate most of the 
anti-TNP response, with some shift occurring during the secondary response. Primers
1 1 1  '
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were capable of amplifying more Ig VH sequences early in the response than at later time 
points and there was difficulty retrieving more than a few clone sequences late in the 
response (Table VH). Whether this is indicative of a shift in VH gene utilization to one 
of the families for which we were unable to obtain sequence due to possible primer 
constraints, or whether this indicates that there are VH gene families yet to be identified, 
awaits additional experimentation and/or the improved design of FCR primers such that 
all VH gene families can be amplified (at least, in naive fish). Another possibility is that 
relatively less clonal expansion occurred later in the response for this trout (# 9) and there 
were fewer recombinant clones containing VH-specific DNA from which sequence could 
be obtained.
To gain an estimate of the actual size of the gene family it is necessary to use 
gene titration analysis, as VH family size can be quite variable (1-500 or more in the 
mouse model) (Livant et al. 1986); thus simple Southern analysis of positive restriction 
fragments would be insufficient. Our analysis of the size of an anti-TNP coding VH 
family was conducted by gene titration analysis using the probe generated from a PCR- 
amplified sequence which is homologous to Ig VH family V by BLAST analysis (# 9 
week 35 consensus sequence). The decision to use a late response, mutated sequence for 
probe production was made in an attempt to identify VH sequences with the greatest 
sequence homology to the VH family utilized and the germline gene whose mutated
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product was selected for the anti-TNP response. As can be seen in figure 22. family V 
appears to demonstrate that minimally 5 VH genes may exist in this family, however, 
family composition analysis must await sequencing of the individual probe-reactive 
bands. As a control, a gene titration experiment was conducted using a probe generated to 
the Cpl sequence (which should only possess one copy per haploid genome). As can be 
seen in figure 23, the degree of reactivity is commensurate with one gene copy per 
haploid genome.
N-Terminal Sequencing
As observed in a previous section, newly emergent Ig heavy chain spots were 
identified that were coincident with observed TNP affinity shifts which occurred at weeks 
10 - 35. Immunopurified plasma antibodies from trout #9 (week 35) were 
electrophoresed and transblotted to PVDF membranes in order to isolate distinct H chains 
for N-terminal sequencing. The most abundant of the newly emergent H chain spots 
(pi 6.1) was excised from Coomassie stained, transblotted membranes and sent to the 
protein sequencing core facility at Louisiana State University Medical Center (Fig. 24).
It was expected that such sequences would be diagnostic as each VH family N-terminus 
was unique (Table IX) and allow for clear identification of the VH gene family utilized 
for the isolated antibody heavy chain. Initial sequence results, however, indicated a
113
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Figure 22. Quantitative Gene Titration - IgVH Family V probe. Genomic DNA (gDNA) 
(10 pg) from an outbred Shasta strain rainbow trout hybridized with a trout Ig VH family 
V (anti-TNP) cDNA probe labelled with 33P-dATP. Titrated amounts of plasmid DNA 
containing a range of genomic equivalents (GE) was also digested and run out to 
quantitate the VH gene copy number (range 1-50 GE). Restriction enzymes used to 
digest the gDNA are annotated on the autoradiograph. The genomic equivalent plasmid 
DNA was digested with Eco RI.
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1, 5, 10 ,15 ,20 ,30 ,40 ,50  GE
gDNA
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Figure 23. Quantitative Gene Titration - Cy. 1 probe. Genomic DNA (5 pg) from 
two outbred Shasta strain rainbow trout hybridized with a trout Ig Cp 1 cDNA probe 
labelled with 33P-dATP. Titrated amounts of plasmid DNA containing a range of genomic 
equivalents (GE) was also digested and run out to quantitate the VH gene copy number 
(range 1 - 1 0  GE). Eco RI was used to digest the gDNA and plasmid genomic equivalent 
DNA.
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Figure 24. Resolution o f discrete H chain products from immunopurified anti-TNP (trout 
n9 week 35). A 2D-DEF / SDS-PAGE gel was transblotted onto PVDF membrane and 
stained with Coomassie blue. Individual ‘spots’ were excised from the membrane and 
sent out for N-terminal amino acid sequencing. Circle indicates the heavy chain protein 
(pi 6.1) that initial sequencing attempts indicated was blocked at the N-terminus. H chain 
molecular weight is 72 kD and L chain molecular weight is 25 kD.
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H chain
L chain
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Table IX. Figure N- terminal sequences of trout antibody VH families based on translation 
of cDNA sequences from the GenBank database. Family designations follow that of 
Roman et al. 1996. Bold text indicates a diagnostic sequence which may be used 
to differentiate families.
family I QTLTE SGPW KKPLE AHKLT
QTLTE SGPW KETGE AHKLT
family V QTLTE SGPW KKPGE SHKLT
Q TLTE SGPGX KEAGE SNTLS
family II QSUBS TPSSP
family HI QTELST QFGSL
family IV EEMDQ SPS& J
family VI YELSQ E A SC
EELSQ E fta c f
family VII I£LSQ m m /
family VIII QIVLT QAESV
family IX QSLTS SESW
family X DXELiX QSGEV
family XI ISLTS SPAQL
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blocking group was impeding the identification of N-terminal sequence and other 
investigators attempting to obtain Ig VH N-terminal sequence have encountered this 
problem (Scott et al. 1988). This result led to the implementation of a variety of 
procedural changes as suggested by the sequencing facility to improve the chance of 
successfully identifying the five to fourteen N-terminal amino acid residues required for 
assignment of the specific protein heavy chain to its VH gene family. If, in fact, the 
isolated H chain is a member of VH family V, the N-terminus is a glutamine residue 
which could inherently possess a pyroglutamyl blocking group (Tsunasawa et al. 1998). 
As such, while no definitive evidence of family V assignment has be obtained, the result 
of a blocked N-terminus for this protein may corroborate the molecular data that indicates 
the anti-TNP response engenders trout Ig VH family V utilization.
Modifications that were made to the original protocol to blot individual H chain 
"spots" to a PVDF membrane for N-terminal sequencing included changing the transblot 
buffer solution from a general purpose buffer containing glycine to CAPS (3- 
[cyclohexylamino]-l-propanesulfonic acid) buffer which does not contain glycine. This 
was done to alleviate the possible introduction of pyroglutamyl blocking groups as a 
procedural artifact and to decrease the stain/detain incubation times which has been 
shown to introduce N-terminal blocking groups (pers. comm. Dr. Jim Carlton. Louisiana 
State University Protein Sequencing facility). Additionally, the amount of protein
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submitted for sequencing was greatly increased from 10 pmol to mmol amounts, which 
generally translated to eight to ten protein "spots" from an initial sample concentration of 
40 pg protein. However, to date, all attempts to obtain the N-terminal protein sequence 
were unsuccessful and no definitive evidence supporting the molecular identification of 
Ig VH gene utilization during the antigen-specific immune response was collected.
Trout Antibody Response to IHNV
Serological Analyses 
Antibody Titers / Affinity
The animals that were immunized with IHNV gp peptide-BSA produced IHNV 
specific antibodies (Fig. 25). The titers of these antibodies, however, would not be 
considered high if compared to animals immunized with whole virus, as the coating 
antigen in the assay is whole IHNV, yet the antibodies produced during this study were to 
one antigenic epitope within the viral glycoprotein’s exposed surface.
As hapten-inhibitor methods cannot be used to assess antibody affinities to 
protein antigens, a denaturant based assay was applied. This assay, termed the 
diethylamine (DEA) shift assay, has been used in measuring avidity differences in human 
antibody responses to the rubella virus (Thomas and Morgan-Capner 1991). However, 
prior to executing these studies the validity of the method was tested using our anti-TNP
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 25. Anti-IHNV titers. This graph illustrates anti-IHNV ELISA results of 
individual trout immunized with an IHNV 20-mer gp epitope conjugated with BSA at 
weeks 0, 5. 10, 20, and 35. The x-axis denotes the time of sample collection and the y- 
axis denotes the units of specific anti-IHNV antibody activity pi'1 plasma.
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plasma. Testing these samples permitted us to determine if a direct correlation existed 
between DEA shifts and absolute affinity changes, thus verifying this assay for use with 
trout plasma. The results obtained from anti-TNP plasma samples having previously 
been shown to possess low. medium, and high affinity subpopulations substantiated the 
assay's utility. Plotting the percent stable antibodies (those which did not shift in O D ^  in 
the presence of DEA in the dilution buffer) against the average mean affinity for each 
subpopulation illustrates that greater shifts occur with lower affinity antibodies 
(Fig. 26). The only drawback in comparison between the two assays is that the TNP 
affinity ELISA provides a quantitative measure of the various subpopulations of antigen- 
specific antibodies whereas the DEA shift ELISA can only be semi-quantitative. 
Nevertheless, this assay provides definitive identification of samples possessing increased 
affinity and was sufficient for our purpose of identifying the individual trout which 
expressed affinity shifts.
Using the DEA shift assay, only one individual (trout #13) was shown to produce 
antibodies possessing increased / high affinity receptors for IHNV as measured by the 
stability of IHNV-specific antibody titers in the presence of 35 mM DEA (Fig. 27).
Thus, RNA samples from this fish were selected for subsequent molecular analyses after 
week 10 DEA assay results were obtained.
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Figure 26. Comparison of average weighted affinity (aK) and DEA percent stable values 
for trout anti-TNP plasma samples. This was done with TNP samples to validate the 
assay for use in measuring antibody affinity / avidity shifts in anti-IHNV plasma samples. 
As illustrated, high affinity antibodies are increased in percent stability in the presence of 
DEA compared to antibodies of medium or low TNP affinity.
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Figure 27. Diethylamine (DEA) shift ELISA reveals that of the five rainbow trout 
immunized with an IHNV 20-mer gp epitope conjugated with BSA, only one individual 
(#13) maintains affinity for IHNV in the presence of 35 mM DEA
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IEF of IHNV-Specific H Chains
Isoelectric focusing of whole plasma from trout #13, followed by second 
dimension SDS-PAGE revealed production of a few new Ig heavy chains over the course 
of the immune response monitored in this study (Fig. 28). There was a dramatic increase 
in production of the Ig heavy chain (pi 6.4) at week 20 compared to the week 5 profile 
and additional heavy chain IEF spectrotypes were observed, one at pi 5.4, another 
between 5.4 - 5.5. and two more between 5.7 - 5.8, which may have been present in 
diminished concentration at week 5 (Fig. 29). Additional light chain pis were also 
observed to emerge over the course of the experiment for this individual although 
densitometry was not undertaken. In contrast, in trout #11 which possessed a similar 
anti-IHNV titer but did not develop antibodies with increased affinity for IHNV, no 
apparent change in Ig hea^y chain isoelectropherotypes was observed (Fig. 30) and this
t
result was confirmed densitometrically (Fig. 31).
Initial experimental design was to immunoprecipitate IHNV-specific antibodies 
for the 2D IEF / SDS-PAGE experiments. However, as revealed by analysis of the 
unpurified plasma samples from affinity shift responders versus non-responders, we were 
able to identify H chain profiles without the costly purification step. This was supported 
by the result that 2D IEF / SDS-PAGE of non-affinity shift responders from TNP-KLH or
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Figure 28. Two dimensional IEF /  SDS-PAGE gels of plasma from trout #13 which 
was immunized with IHNV-gp peptide-BSA emulsified in Freunds complete adjuvant 
and shown to possess an antibody affinity shift as measured by the DEA affinity shift 
assay over the course of the experiment. A. Five pg of plasma from week 5 run out on a 
gel and silver stained. B. An equivalent amount of plasma from week 20 reveals a 
heavy chain protein profile possessing new H chain isoelectropherotypes compared to the 
earlier profile (indicated by circles). Purified trout antibody (H chain 72 kD, L chain 25 
kD) is included on the gel as a molecular weight marker.
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Figure 29. Densitometric profile of silver stained 2D EEF /  SDS-PAGE gels at 72 kD. 
(A) Profile of anti-IHNV trout # 13 plasma week 5. (B) Profile for same trout at week 
20. This trout did evidence a shift in antibody affinity profiles as measured by the DEA 
shift ELISA which correlates to the emergence of new H chain isoelectropherotypes. The 
x-axis represents the pi range and the y-axis denotes optical density (OD).
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Figure 30. Two dimensional IEF / SDS-PAGE gels of plasma from trout #11 immunized 
with IHNV gp peptide-BSA emulsified in Freunds complete adjuvant which did not 
evidence an antibody affinity shift as measured by the DEA affinity shift assay. A. Five 
pg of plasma from week 5 run out on a gel and silver stained. B. An equivalent amount 
of plasma from week 20 reveals a heavy chain protein profile which is unchanged 
compared to the earlier profile. Purified trout antibody was included on the gels as a 
molecular weight marker, of which only the H chain (72 kD) is visible.
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Figure 31. Densitometric profile of silver stained 2D EEF /  SDS-PAGE gels at 72 kD. 
(A) Profile of anti-IHNV trout #11 plasma week 5. (B) Profile for same trout at week 
20. This trout did not evidence a shift in antibody affinity as measured by the DEA shift 
ELISA. The x-axis represents the pi range and the y-axis denotes optical density (OD).
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IHNV gp peptide-BSA did not possess new IEF spectrotypes (Fig. 17, 30) and neither did 
the PBS injected control (Fig. 19).
Molecular Analyses
Panning for IHNV-Specific B Cells
At each sampling point, peripheral blood lymphocytes were panned in an attempt 
to monitor temporal changes in VH gene sequence as described above with the following 
modification. Peripheral blood leukocytes were co-incubated with IHNV conjugated 
magnetic beads instead of TNP-BSA coated beads . Virtually 100% of the panned 
lymphocytes recognize IHNV, whereas the non-adherent cells did not recognize the viral 
glycoprotein epitope(s).
cDNA Sequences
Total RNA was isolated from panned, IHNV-specific B cells from each fish and 
stored at -80° C until at least one fish (# 13 in this study) was identified as exhibiting a 
significant Ab affinity shift. cDNA clones were then produced for sequence analysis. 
Table X illustrates the primers which amplified IHNV- specific template from this 
individual as well as from trout # 14, a non-affinity shift responder. Both individuals 
produced clones that were homologous to trout VH family IV and the deduced amino
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acid sequence of the EHNV-specific DNA with representative sequence at each sampling 
time point was determined (Table XI). No replacement mutations were observed to occur 
at any time point for trout #  13 in the CDRs and few silent mutations were observed in 
the nucleotide sequence (Table XU).
VH Gene Utilization and Gene Titration
Family IV appears to be utilized for most of the anti-IHNV response generated, 
based on the homology of amplified cDNA sequences compared with Genfiank archived 
trout Ig VH cDNA sequences. To gain an estimate of the actual size of this gene family, 
an anti-IHNV coding VH cDNA probe (from #13 week 35) was used to conduct gene 
titration analysis as previously described. As evidenced by the results shown in figure 
32, genomic DNA digested with Eco RI, Eco RV, or Hind HI and probed with the Ig VH 
family IV probe demonstrates that many more VH genes may exist in this family 
compared to that of family V, perhaps as many as 30 gene copies. This will make 
characterization of the individual family repertiore and absolute confirmation of somatic 
mutation more complicated than that of the family V repertoire as more sequencing of 
genomic DNA probe reactive fragments will have to be performed. However, as no 
replacement mutations appear to have been generated, verification of the possible 
requirement for somatic mutation to generate a high affinity response is moot.
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Table X. Primers which amplified IHNV-specific trout Ig VH cDNA.
primer i.d.
most homologous 
BLAST specificity
amplify Ag-specific 
template?
G-843/CH1 family V -
G-844/CH1 family IX -
G-845/CH1 family VHI, HI -
G-847/CH1 family V -
G-848/CH1 family V, I -
G-849/CH1 family V -
G-850/CH1 family VH -
G-851/CH1 family V -
G-852/CH1 family IV + IHNV
G-853/CH1 family IV + IHNV
FR1/FR3 family IV + IHNV
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Table XI. Representative lHNV-spccific VH cDNA - deduced amino acid translations.
FR1 CDR1FR2 CI)R2 FR3
wk 0 LSCKISGFDMTNYYMHWIRQKPGKALEWIGRINSGSTDAPVYSDSLKGQFTLTEDVSTSTQSLEAKSLGSEDSAVYYCAR 
Wk5 LSCKISGFDMTNYYMHWIRQKPGKALEWIGRINSGSTDAPVYSDSLKGQFTLTEDVSTSTQSLEAKSLGSEDSAVYYCAR 
W k 10 LSCKISGFDMTNYYMHWIRQKPGKALEWIGRINSGSTDAPVYSDSLKGQFTLTEDVSTSTQSLEAKSLGSEDSAVYYCAR 
Wk 20 LSCKISGFDMTNYYMHWIRQKPGKALEWIGRINSGSTDAPVYSDSLKGQFTLTEDVSTSTQSLEAKSLGSEDSAVYYCAR 
wk 3S LSCKISGFDMTNYYMHWIRQKPGKALEWI GRINSGSTDAPVYSDSLKGQFTLTEDVSTSTQFLEAKSLSSEDSAVYYCAR
Table XII. IHNV-Specific VH cDNA highlighting mutations. Consensus sequences are 
denoted by an *. Replacement mutations are indicated by a red nucleotide. Of all the 
cDNA sequences in this table, only one had a replacement mutation in a CDR (wk 10, 
CDR2. Pro 59 —>Ser 59) and three late sequences had replacement mutations in a FR 
(wk 35, FR3, Ser 81 —>Phe 81 and Gly 88 —»Ser 88).
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wk 0 AAACTATTACATGCACTGGATAAGACAGAAACCAGGCAAAGCTCTGGAGT  
( n = l 0 )
GGATTGGGAGAATTAACTCTGGTTCAACAGATGCTCCAGTCTACTCAGAC
TCCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAGCACACA
ACAGTCCTTAGAGGCCAAGAGTCTGGGTTCAGAGGACTCTGCTGTTTATT
ATTGTGCTCGAGA
Wk 5 AAACTATTACATGCACTGGATAAGACAGAAACCAGGCAAAGCTCTGGAGT  
 ^ Q_ 0 )
GGATTGGGAGAATTAACTCTGGTTCAACAGATGCTCCAGTCTACTCAGAC
TCCCTC-AAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAGCACACA
ACAGTCCTTAGAGGCCAAGAGTCTGGGTTCAGAGGACTCTGCTGTTTATT
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
ATTGTGCTCGAGA
wk 10 AAACTATTACATGCACTGGATAAGACAGAAACCAGGCAAAGCTCTGGAGT
GGATTGGGAGAATTAACTCTGGTTCAACAGATGCTCCAGTCTACTCAGAC  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * T * * * * * * * * * * * * *  *
TCCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAGCACACA
ACAGTCCTTAGAGGCCAAGAGTCTGGGTTCAGAGGACTCTGCTGTTTATT
ATTGTGCTCGAGA  
★ ★★*★ ★★★★★★★★
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w k  2 0  A A A C TA T T A C A T G C A C T G G A T A A G A C A G A A A C C A G G C A A A G C T C T G G A G T
(n=8) I T * * * * * * * * * * * * * - * * * * * * * * * * * * * * * * * - * * * * * * - * * * * * * * * * *
GGATTGGGAGAATTAACTCTGGTTCAACAGATGCTCCAGTCTACTCAGAC
TCCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAGCACACA
ACAGTCCTTAGAGGCCAAGAGTCTGGGTTCAGAGGACTCTGCTGTTTATT
ATTGTGCTCGAGA  
★ ★ ★ ★ • * • ■ * ■ ★ ★ ★ ★ *
w k  3 5  AAACTATTACATGCACTGGATAAGACAGAAACCAGGCAAAGCTCTGGAGT  
( 9 )
GGATTGGGAGAATTAACTCTGGTTCAACAGATGCTCCAGTCTACTCAGAC
TCCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAGCACACA
ACAGTCCTTAGAGGCCAAGAGTCTGGGTTCAGAGGACTCTGCTGTTTATT
* w * * *  * T , *  * * * * * * * * * A * * * * * * * * * * * *  X „ , - * * * * »  ,  * * *  *
ATTGTGCTCGAGA
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Figure 32. Quantitative Gene Titration - IgVH Family IV  probe. Genomic DNA (gDNA) 
(10 |ig) from an outbred Shasta strain rainbow trout hybridized with a trout Ig VH family 
IV (anti-IHNV) cDNA probe labelled with 33P-dATP. Titrated amounts of plasmid DNA 
containing a range of genomic equivalents (GE) was also digested and run out to 
quantitate the VH gene copy number (range 1 - 5 0  GE) Restriction enzymes used to 
digest the gDNA are annotated on the autoradiograph. The genomic equivalent plasmid 
DNA was digested with Eco RI.
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N -Terminal Sequencing
Nr-terminal sequencing of the antibody heavy chain spot (pi 6.4) that was 
observed to markedly increase in production during the anti-IHNV immune response is 
awaiting the refinement of the transblot procedure as determined to be required after 
attempts to obtain anti-TNP heavy chain N-terminal sequence proved unsuccessful (see 
earlier section). An additional modification to the procedure employed for obtaining 
IHNV specific heavy chains was necessitated due to the expense of the original 
purification method. In the original experimental design it was believed that 
immunoprecipitation of virus specific antibodies by co-incubation of IHNV and trout 
plasma from late in the response, followed by elution of these antibodies by a standard 
acid/base elution procedure (Harlow and Lane 1988) would be required to provide an 
immunopurified sample for subsequent 2D-EEF/SDS-PAGE. However, purification of 
the mg quantities of IHNV that are required became too costly and time consuming. This 
step will be eliminated in future attempts to isolate IHNV specific heavy chains as these 
studies have demonstrated they can be isolated and visualized readily by 2D-EEF/SDS- 
PAGE of unpurified plasma (Fig. 28).
Variability Analysis
The variability plot for rainbow trout Ig VH sequences archived in the Kabat
147
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Database (July 2000 dataset) revealed limited diversity of CDRs (filled bars)(Fig. 33) 
especially when compared to the variability plots for mammalian IgG (Fig. 34) and IgM 
(Fig. 35) archived within the same dataset. The inclusion of ourcDNA sequences and 
additional sequences from GenBank brings the variability characteristics of trout CDR 
closer to the pattern illustrated on the overall variability for Ig VH (Fig. 36). This is 
especially true for CDR2 particularly and for residue 56 which now appears quite 
mutable. This position is generally considered to be an extrinsic hotspot for mutation in 
the mouse (Milstein and Neuberger 1996), meaning this position has been shown to be an 
antigen-selected hot spot, and the observation that trout also possess this particular 
hotspot illustrates that trout VH are more similar to the model of CDR variability than 
previously recognized. It is now felt that the observation that trout VH possessed less 
variability in their CDRs as evidenced in figure 32 is more the result of having a limited 
number of trout VH sequences and (until now) no antigen-selected sequences for 
comparison with the sizeable database of available, antigen-selected Ig sequences from 
other species.
Analysis of the variability of previously archived trout Ig indicated CDR I was 
relatively more variable than CDR2, with the amino acid at position 33 being the most 
mutable. This is one of three positions of increased variability in the comparison of 
IgG/IgM Ig variability plots (along with amino acid residues 31 and 35) but in these plots
148
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Figure 33. Variability plot of all rainbow trout Ig VH region sequences in the Kabat
Database (from the July 2000 dataset, n = 45). CDRs indicated by filled bars, FRs by
clear bars, on the histogram.
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Figure 34. Variability plot of all IgG VH region sequences in the Kabat Database (from
the July 2000 dataset, n = 2343). CDRs are indicated by Filled bars, FRs by clear bars, on
histogram.
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Figure 35. Variability plot of all IgM VH region sequences in the Kabat Database (from
the July 2000 dataset, n = 2597). CDRs are indicated by filled bars, FRs by clear bars, on
histogram.
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Figure 36. Variability plot of all rainbow trout Ig VH region sequences in the GenBank 
Database combined with additional Ig VH cDNA sequences obtained in our laboratory 
(n =117). This dataset is truncated due to experimental design and illustrates the 
variability from amino acid position 27 to 94 (encompasses partial FR1 and all of CDR1, 
FR2, CDR2). CDRs indicated by filled bars, FRs by clear bars, on the histogram.
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CDR2 is. overall, more variable than CDR I. Combining our trout cDN'A sequences with 
the original database sequences for trout strongly indicates a similarity in variability 
between CDR1 and CDR2. with heightened amino acid variability at-position 56.
Although not included in the variability plots presented herein, the CDR3 
sequences amplified in our study possessed the most variability of all trout CDR regions. 
This result is not unexpected as molecular characterization of trout DH and JH cDNA 
sequences (reviewed in du Pasquier and Flajnik 1998) indicates the complexity of teleost 
CDR follows the mammalian paradigm and CDR3 is known to possesses the greatest 
capacity for fine tuning the antigen specificity of individual heavy chains (Johnson and 
Wu 1998).
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DISCUSSSION 
Evidence for Somatic Hypermutation in Trout Ig VH
As previously demonstrated (Zhang 1999: Khor 1997), fish immunized with 
TNP-fCLH produced a specific, high-titered antibody response to TNP. The titers in 
these animals increased over 2000-fold during the first ten weeks post immunization. As 
the goal of this research was to determine if the accrual of somatic variants could be 
observed during a phase of affinity maturation, peripheral blood lymphocytes were 
isolated for analysis of VH cDNA sequences, while the plasma from these same samples 
were analyzed for increases in affinity and spectrotype changes. Thus, it could be 
determined not only whether somatic variants arise during the immune response, but if 
the induction of these variants correlated with affinity increases and physical changes in 
antibody structure. In the present study, accumulation of variants were identified in TNP 
immunized trout which correlated to the emergence of new H chains and an affinity shift 
in these fish.
Both Khor (1997) and Zhang (1999) observed that the majority of TNP-KLH 
immunized trout underwent affinity maturation; however, in a number of cases the 
individual antibody subpopulations never exceed the highest affinity exhibited initially at 
week 0. Therefore the possibility existed that although the overall affinity (e.g. the 
weighted average) may consistently increase over time, there may have simply been an
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antigen-driven selection of pre-existent high affinity clones. Thus affinity maturation 
could simply be the skewing, or preferential induction, of primarily the highest affinity 
clones which were innately available. However, there were select, specific cases wherein 
new and higher affinity subpopulations would arise only late in the response (> 10 weeks) 
and this prompted the consideration that high affinity somatic variants may only arise 
post antigen-induction, then selectively induced with the diminishing concentration of 
antigen overtime (Zhang 1999).
One objective of this study was the generation of sufficient cDNAs from antigen- 
specific lymphocytes to analyze the expressed repertoire. The experimental strategy used 
was to periodically bleed the fish and test their plasma, while preserving the cDNA for 
each animal at that specific phase of the response until the affinity shift responders could 
be clearly identified by serological assay. At the completion of the sampling regime, the 
individuals that demonstrated the greatest degree of affinity maturation, those possessing 
late appearing, higher affinity subpopulations and unique antibody heavy chain 
isoelectropherotypes, were selected for molecular characterization of the antibody 
response as these individuals would be the most likely candidate(s) for somatic mutation. 
Thus, the total cDNA was screened via the use of primers specific for each of seven of 
the eleven known VH families.
Of the five individuals immunized with TNP-KLH, trout #9 and #10
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
demonstrated the greatest increase in affinity (Fig. 12. 13), with the appearance of unique 
high affinity subpopulations later in the response. These affinity subpopulations ranged 
in aK from 3.8 to 5.6 at week 5 and 4.4 to 6.2 at week 20 for #9 and from 4.2 to 5.6 at 
week 5 and 4.6 to 6.6 at week 20 for #10, respectively, whereas the highest affinity 
observed at week 35 was for trout #9 with an aK of 6.6 - 6.8. The mean percentage of 
antibodies (of trout #9 and #10 comparing weeks 5, 10, and 20) with these new, higher 
affinities for the primary TNP response was 46.7% (Fig. 37). The secondary TNP 
response measured for week 35 trout #9 revealed an additional percentage of almost 10% 
for the subpopulation possessing the aK of 6.6 - 6.8 (Fig. 12). Thus, this 
immunochemical analysis strongly suggested that unique higher affinity, antigen-specific 
B lymphocytes were emerging late in the response and becoming increasingly dominant 
within the individual. As further evidence that unique antibody species were being 
produced at this point, isoelectric focusing of non-purified plasma as well as 
immunopurified antibodies was performed. Coincident with increase in affinity, these 
individuals expressed new antibody heavy and light chains. Thus, the late emerging 
antibodies not only possess uniquely increased affinities but also physically distinct 
antibodies. Again, this finding is consistent with the induction of somatic hypermutation. 
The appearance of these new isoelectropherotypes was unique to the trout demonstrating 
affinity maturation, as trout which did not exhibit affinity maturation (non-affinity shift
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Figure 37. Combined TNP affinity profile averaging the aK for trout #9 and #10 for 
week 5. 10. and 20 to illustrate the temporal accumulation of new, increased affinity 
subpopulations. The aK range of each subpopulation is depicted on the x-axis and the 
percent of the antibody pool possessing that affinity on the y-axis.
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individuals) (Fig. 17. 30) or fish injected with PBS emulsified in adjuvant (Fig. 19) 
revealed no altered isoelectropherotvpes.
The anti-IHNV response, however, seemed to use a different mechanism of 
affinity maturation than that of the anti-TNP response. Whereas the TNP individual 
possessed somatic variation in the CDRs which was coincident with the development of 
new LEF spectrotypes, the IHNV response appears to have been simply an antigen-driven 
selection of pre-existent high affinity clones. This has been noted to occur in the murine 
immune response against other viruses, such as vesicular stomatitis virus, which has also 
been shown to possess an innate subpopulation of high affinity VSV neutralizing 
antibodies (Andersson et al. 1998) that is stimulated to proliferate after exposure to 
antigen. Optimal protection against pathogenic Streptococcus pneumoniae has also been 
traced back to germline T 15 anti-phosphorylcholine antibodies which do not undergo 
somatic mutation to further increase antigen specificity (Briles et al. 1982). Thus, 
affinity maturation in fish may also be a product of skewing, or preferential induction, of 
primarily the highest affinity clones which were innately available and this is not 
necessarily to be construed as a more primitive antibody immune response .
On the basis of this immunochemical analysis, cDNAs generated from 
lymphocytic RNA isolated from antigen-specific B lymphocytes were analyzed using 
primer sets designed to recognize known trout Ig VH families. Whereas unselected
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lymphocytes produced cDNA reactive with the majority of VH primers in our possession 
(Table X), these same primers identified cDNA from TNP-panned lymphocytes as being 
family V sequences (Table V) and those from IHNV-panned lymphocytes as being 
family IV (Table XI). Dr. Trond Jorgensen's research group (University of Tromso. 
Tromso. Norway) generated a recombinant phage expression library of Atlantic salmon 
VH genes, and in testing the reactivity to TNP of antibodies derived from these 
constructs, found that family V was also used (Solem et al. 2000). As Atlantic salmon 
and rainbow trout possess homologous family specific sequence designations, the 
utilization of family V for the anti-TNP response was indirectly corroborated by this 
study. These results have revealed, for the first time, which specific VH gene family is 
used by trout to produce two different antigen-specific responses.
As can be seen from Table VH, the representative deduced anti-TNP amino acid 
sequences through week 5 are the same as the (banked) germline sequences. However, 
by week 10, a time at which affinity maturation is detectable by serological assay, 
potential somatic mutations begin to accrue. There are a number of essential features that 
should be noted and are consistent with the induction of somatic mutations in mammals. 
First, the mutations occur almost exclusively within the CDR regions (primarily CDR2). 
Second, the majority of observed mutations are replacement mutations and not silent 
mutations. Finally, the fact these variants can be easily detected from the random
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cloning of only seven to ten cDNA sequences infers that the lymphocytes bearing these 
variants have come into clonal dominance.
Thus, although the process of somatic mutation is somewhat random, yielding 
both silent as well as replacement mutations (Storb 1996), the fact that replacement 
mutations in the antigen contact regions of trout VH are coming into dominance is 
indicative that they are being selectively expanded. In the mammalian system, germinal 
centers have been identified as the physical microenvironment in which antigen selection 
occurs (MacLennan 1994). Germinal centers have not been identified in rainbow trout, 
however, the results indicate antigen selection of pre-existent high affinity B cell clones 
and antigen-driven somatic hypermutation does occur in fish. This suggests that the 
localized microenvironment of germinal centers is either (1) not entirely requisite for the 
antigen selection of high affinity B cell clones to occur or (2) this microenvironment has 
yet to be identified in teleost fish.
The variability plot combining new and banked trout VH (deduced) sequences 
illustrates what is felt to be a more realistic estimate of the variability of CDRs, 
particularly the CDR2, over what was indicated by previous variability analysis. 
Additional methods such as Shannon entropy analysis have been used by others 
investigating Ig variability in fish, including analysis of sturgeon (Lundqvist et al. 1998) 
and Atlantic charr (Widholm et al. 1999). Although not included in our variability plots,
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additional trout Ig VH cDNA sequences were amplified that confirm that trout CDR3 
variability is greater than that of CDR.1 and CDR2, which follows the mammalian model 
of hvpervariable regions and increased plasticity in CDR3 over other CDRs.
Although the variability plot of all trout VH sequences to date (inclusive of this 
study and GenBank contributions) revealed a CDR variability more consistent with that 
observed for mammalian Ig in the Kabac database. However, other investigators have 
argued that variability plots may not be the best method available to characterize the 
variability of low sample size Ig VH sequences. Per Stewart et al. (1997). the use of 
Shannon entropy analysis is an improved method for this type of study in that variability 
plots have a primary limitation and account for only the most common one or two amino 
acids in estimating diversity. This may lead to an underestimate of low diversity or an 
exaggeration of high diversity in instances where overall sample number is low. 
Additionally, Gex-Fabry et al. (1989) also argues against the use of Wu and Kabat 
criteria for identification of CDRs when only a small number of sequences are available 
for analysis. These authors believe that using the Wu and Kabat method with a small 
sample number inherently leads to flawed identification of CDRs when originally 
distinguishing CDRs from FRs in newly described Ig or Ig-related molecules. They, 
therefore, have developed a method which takes into account the type of substitution 
which occurs, coupled with a statistical criterion for classifying a site as CDR or FR.
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VH Genes and Gene Families
The findings described in the previous section are very supportive of the 
induction of somatic mutation, however absolute confirmation requires that all possible 
germline sequences of family V be identified and sequenced. To date, this has been a 
weak area of comparative molecular immunology as 53 of the 56 archived VH gene 
sequences are cDNA (GenBank). The studies reported here represent an initial step in 
characterizing the trout Ig VH gene repertoire. Gene titration experiments were executed 
using cDNA clone sequences from late in the TNP or EHNV response for family specific 
probe production. Late response cDNA sequences were selected in an attempt to 
hybridize germline sequences closest to these antigen-selected sequences in the family 
repertoire. Examination of these blots reveals that minimally 1 -5  germline genes may 
exist for family V but that the family IV repertoire is much more complex (Fig. 22, 32).
The complexity contrasted between the two trout VH families is reflective of the 
dissimilarity of VH gene repertoire size in both the mice and humans. The mouse has 
been shown to possess 15 VH gene families, and it is believed that all murine VH gene 
families have been identified since Southern blot experiments screening 2,000 cDNA 
clones against Cp and JH probes revealed that all possessed VH regions with sequence 
homology that could be traced to the described 15 VH regions (Mainville et al. 1996).
167
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The family number, name, and complexity (in terms of estimated murine germline VH 
sequences in each family) is presented in Table XIII. A similar table for human VH 
region families is also provided for comparison (Table XIV) and illustrates that there are 
seven human VH families identified to date and that the complexity of these families, 
while less, overall, than that of murine VH families (mouse complexity ranges from 1 
germline sequence identified for the VH12 and VH13 families, ranging up to as many as 
1000 germline sequences for the VH1 family (Kofler et al. 1992). Human VH 
complexity ranges from 1 germline sequence for the VH6 family up to 46 germline 
sequences identified for VH3 (Cook and Tomlinson 1995). Thus, the gene titration 
analysis for trout clearly illustrates that the inherent complexity of trout VH gene families 
is on the level of that observed in higher vertebrates.
An additonal question which must be addressed for trout VH is the question of 
how germline VH genes are arrayed along the chromosome(s). In the murine system, it 
has been observed that adjacent VH genes are generally members of the same VH gene 
family, generally found in a clustered arrangement, and are oriented in the same direction 
5’ —» 3' (Kemp et al. 1979; Bothwell et al. 1981).(Fig. 38) They are also spaced about 
seven to Fifteen Kb apart along the chromosome (Givol et al. 1981). This differs in 
humans, in that studies using phage and cosmid clones of human VH genes demonstrated 
extensive interdigitation of human VH gene familes (Walter et al. 1990,1991) as opposed
168
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table XIII. Murine Ig VH gene families. Although presented with the VH# designation 
foremost, murine VH gene families are more commonly referred to by the “name" designation 
in the middle column. This “name" designation is a carryover from early identification of 
families by hybridization against various myeloma VH sequence probes and is not a 
classification used when identifying human Ig VH genes (Brodeur and Riblet 19S4).
family num ber name complexity
VH1 J558 6 -1000
VH 2 Q.52 15VH 3 30-60 5 -8
VH 4 X-24 0
VH 5 7183 12
VH 6 J606 10- 12
VH 7 S107 3
VH 8 3609 7 -1 0
VH 9 VGAM3-8 5 -7
VH 11 CP3 1 -6
VH 12 CH27 1
VH 13 3609N 1
VH 14 SM7 3 - 4
VH 15 VH15 2
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Table XIV. Human Ig VH gene families. The complexity refers to how many 
individual genes have been identified for the family (Cook and Tomlinson 1995).
family num ber complexity
VH1 14
VH2 4
VH3 43
VH4 9
VH5 0
VH6 I
VH7 5
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Figure 38. Map of the murine VH loci. Depicted are approximate map positions for the 
Fifteen known mouse VH gene families. Each rectangle represents a gene cluster and 
illustrates the general tendency towards a clustering of genes within each family, 
although some interdigitation between families occurs (after Kemp et al. 1979; Bothwell 
etal. 1981).
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to the clusters of discrete family-specificVH loci in mice (Fig. 39). Knowledge of the 
mouse and human arrangement reveals differences in organization and it would be of 
interest to see whether trout are more like man or mouse in this regard. If affinity 
maturation is possible, as was demonstrated by the anti-TNP response, a lack of affinity 
maturation may indicate that the germline repertoire is better adapted or more extensive 
than one which undergoes affinity maturation. Thus, a VH family which is capable of 
fine tuning an antibody response through the process of somatic mutation might be less 
likely to maintain a large germline repertoire. This would support the observation that 
the trout anti-TNP response accumulated somatic variants over time and utilized VH 
family V, with < 5 genes in the germline. If an animal possesses VH gene family(s) with 
a larger germline repertoire, such as trout VH family IV, the increased repertiore may 
preclude the need for somatic mutation in response to complex antigen(s) (i.e. 
pathogens). This would corroborate the observation that the trout anti-EHNV VH 
sequences did not accumulate somatic variants over time.
Indeed, the murine anti-VSV response presented earlier in this Discussion as an 
example of an antigen-driven selection of pre-existent high affinity clones may also 
strengthen this argument. Mouse anti-VSV antibodies possess high binding avidities 
(~ 109 M'1), are devoid of somatic mutation, and utilize the Q52 VH family for 
production of virus-specific H chains (Kalinke et al. 1996). Q52 VH is possesses the
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Figure 39. Map of the human VH loci. Depicted are the approximate map positions for 
the seven known human VH gene families. Each bar represents an individual gene of a 
prototvpic haplotype (after Cook and Tomlinson 1995) and illustrates the interdigitation 
observed within families.
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second largest germline repertiore of murine VH families, with 15 individual genes 
(Kofler er a/. 1992).
The Use of Model Antigens vs. Complex Antigens
The most informative studies of the immune response have used 
defined antigens such as TNP ( Haines and Siskind 1980: Arkoosh and Kaattari 1991), 
PC (Chang and Rittenberg 1981: Clarke et al. 1983), arsonate (Rothstein and Gefter 
1983), or oxazolone (Griffiths et al. 1984: Berek and Milstein 1987). Even in the trout 
response, studies describing affinity maturation have only been addressed using the 
hapten TNT (Khor 1997; Zhang 1999). This has been problematic in characterizing the 
underlying immune processes occurring to relevant, pathogen-associated antigens in 
teleosts. We attempted to address this issue by measuring the immune response against a 
complex viral antigen, IHNV, using a synthetic gp epitope identified as being 
immunogenic in trout by Mourich and Leong (1991). There are still aspects of this 
approach that need to be resolved, one of which is the ability to measure affinity shifts 
and antibody titers with more complex antigens . We were able to illustrate the 
applicability of the DEA shift assay as a means of identifying trout undergoing an 
affinity maturation response but this is not a quantitative assay, at best semi-quantitative, 
and strategies must be devised to address this constraint when investigating the specific
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immune response with a view to developing diagnostic and/or prophylactic applications.
Additionally, the experimental design was complicated by our decision to boost 
the trout with formalin-killed IHNV for the secondary immunization since plasma EHNV 
titers were not increasing as high as originally expected. In hindsight, this decision 
should not have been made as we were not able to measure a true secondary antibody 
response (the trout were undergoing a primary response to other glycoprotein epitopes 
not contained in the intial immunization) which is the reason only results for the anti- 
IHNV gp response through week 20 are reported within this manuscript.
Future Studies
In conclusion, the novelty of the approach used in this dissertation to investigate 
the antigen-specific immune response, compared to that previously attempted in other 
laboratories, allows the first description of the molecular basis of the trout immune 
response against a defined antigen and a relevant pathogen. The results obtained reveal 
that the piscine antibody response is much more sophisticated than previously described, 
with a capability to fine tune the specific immune response on the molecular level, as 
observed in mammals. However, there are still technical issues to overcome which need 
to be addressed for future studies.
One such issue is the N-terminal protein sequencing of the trout heavy chain
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isoelectropherotypes for verification of VH family usage. For anti-TNP, it is essential to 
determine whether the sequence is, in fact, inherently blocked due to pyroglutamyl 
blocking groups which may occupy the N-terminus of family V heavy chains or whether 
we introduced a blocking group artificially sometime during the isolation process to 
obtain individual heavy chain "spots" for sequencing. If it is a technique-related issue, 
this must be rectified and additional experiments to refine the technique are underway.
If the blocking group is inherent, as may be indicated by the N-terminal glutamine 
residue identified in family V VH sequences identified to date, protein sequencing 
experiments should still be pursued as we may still be able to obtain N-terminal sequence 
for the anti-IHNV gp peptide heavy chain with the case of the family IV VH sequences, 
an aspartate residue should exist at the N-terminus and, thus, might prove more amenable 
to the repeated electrophoretic manipulations required to isolate individual heavy chains. 
One final means of identifying the specific VH family employed for the response against 
either of these antigens was proposed by Zhang (1999) by which cyanogen bromide 
would be used to cleave trout H chains. Cyanogen bromide treatment, which specifically 
cleaves proteins after methionine residues, would produce an electrophoretic profile that 
would permit family identification based on the size of individual heavy chain fragments 
produced (see figure, appendix HI).
Another important requirement for the continuation of this type of investigation is
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the identification and sequencing of germline sequences for as many of the representative 
Ig VH families as possible. There are currently only three germline sequences for trout. 
This is a problem which many comparative immunologists will encounter when 
exploring immunoglobulin binding site production. This problem is not restricted to 
Salmonids. nor teleosts alone as there are few non-mammalian Ig germline sequences 
archived to date. Another avenue ripe for investigation is the inclusion of experiments 
utilizing isogenic strains of rainbow trout and other species for studies of somatic 
mutation as well as for identification of germline Ig sequences.
As new technologies are developed that measure antibody responses, the 
requirement to apply these techniques in comparative studies is becoming more evident. 
Recently, additional evidence for the anti-TNP affinity maturation response in trout was 
presented in which investigators used commercially available biosensor equipment 
(BIAcore biosensor; Pharmacia) to measure off-rates of antibodies for TNP (Cain et al. 
2000). These investigators reported affinity kinetics quite similar to those we measure by 
affinity ELISA . The biggest drawback to employing these types of cutting edge 
technology is the cost and lack of reagents developed for use with lower vertebrate 
animal models.
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SUMMARY
This is the first comparative immunogenetics study which illustrates the accrual 
of somatic mutations temporally over the course of an antigen-specific immune response 
in rainbow trout. This accumulation of somatic variants, primarily in the CDR2 region 
of the Ig VH, corresponds with the emergence of new heavy chain isoelectropherotypes 
and affinity maturation. Thus, the trout’s specific immune response to a defined hapten, 
TNP, clearly reveals an adaptability of the teleost immune response which was heretofore 
characterized as quite restricted. New antibody heavy chain isoelectropherotyes were 
also observed to come into dominance during the anti-TNP response and an isolated 
heavy chain (pi 6.1) has been identified as a suitable candidate to provide for N-terminal 
sequencing in an effort to provide corroborative data to support putative Ig VH gene 
utilization during the TNP antibody response.
Analysis of the response against the IHNV glycoprotein epitope revealed no 
replacement mutations in the VH over the course of the study but apparently a pre­
existing antibody subpopulation was stimulated to proliferate upon immunization against 
this antigen. This was illustrated by densitometric analysis of the 2D-IEF/SDS-PAGE 
profile of antibodies sampled over the course of the experiment which revealed marked 
increase in production of an individual antibody heavy chain (pi 6.4) later in the response 
over the other heavy chain components of the plasma sample in a trout identified as an
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affinity shift responder. Additional antibody heavy chain IEF spectrotypes were also 
produced during the anti-IHNV response but whether these proteins were produced by 
the same Ig VH family as that which was isolated and cloned during the study awaits 
completion of N-terminal protein sequencing of these individual heavy chains.
Germinal centers have not been identified in rainbow trout, however, our results 
indicate selection of pre-existent high affinity B cell clones and antigen-driven somatic 
hypermutation does occur in fish and is suggestive that the localized microenvironment 
of germinal centers is either (I) not entirely requisite for the antigen selection of high 
affinity B cell clones to occur or (2) this microenvironment has yet to be identified in 
teleost fish.
The DEA shift assay was validated for use in the study of antibody affinity / 
avidity shifts against complex antigens when a traditonal inhibitor assay is unavailable 
and should be considered for use by other investigators. Although it is clearly easier to 
demonstrate the molecular and serological processes occurring during an antibody 
response when using defined antigens such as TNP, one important aspect of studying 
antigen-specific immune responses lies within the context of being able to identify and/or 
engender antibody responses that positively impact an animal's health and well-being.
Finally, this study provides the first correlative data of specific Ig VH gene family 
utilization with antigen-specific immune responses in lower vertebrates with quantitative
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results regarding the gene copy number for these VH gene families in individual, outbred 
Shasta strain rainbow trout. Preliminary results indicate that trout VH gene families are 
no more, or less, complex in germline repertoire than the mouse or humans, and that their 
specific immune response is no less retricted than either of these higher vertebrate 
species. The application of Ig VH gene titration methods such as those employed in our 
laboratory to the study of isogenic strains of trout will provide additional insight into the 
complexity of the various trout Ig VH families described to date. The technique is also 
an important tool with application for assessing the pre-existing capacity for an antigen- 
specific immune response in various trout populations.
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Note: Ultrapure water produced by a NANOPURE ultrapurification system 
manufactured by Bamstead is used for all buffer and reagent formulations below.
ABTS (2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) Developer Solution
Citrate Buffer
Citric acid 0.2 g
H:0  80 ml
HC1 to pH 4
H:0  to 100 ml
ABTS solution
ABTS 0.1 g
H:0  10 ml
30 % H20 2
Make immediately prior to use by combining 4.8 ml citrate buffer with 200 pi 
ABTS solution and 5 pi H20 2 for each ELISA plate to be developed.
Cacodylate Buffer (0.28 M)
Cacodylic acid 44.8 g
NaOH 0.9 g
H;0  to 800 ml
HC1 to pH 7.0
H.O to 1L
CAPS Buffer for Electroblotting Proteins
10X CAPS, pH 11 100 ml
MeOH 100 ml
H;0  to 800 ml
ELISA Coating Buffer
Na2HC03 0.795 g
NaHCOj 1.465 g
H20  to 450 ml
NaOH to pH 9.6
H-,0 to 500 ml
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IEF Buffers
Cathode (Upper chamber) Buffer
NaOH 0.2 g
H:0  to 250 ml
Chill to 4° C, then de-gas.
Anode (Lower chamber) Buffer
H3PO, 0.34 ml
H:0  to 500 ml
Chill to 4° C before use.
IEF Lysis Buffer
Urea 5.7 g
20% NP-40 1.0 ml
Ampholytes (pi range 3-10) 0.5 ml 
2-Mercaptoethanol (w/v) 0.45 ml
H;0  to 10 ml
Mix all ingredients until dissolved and aliquot into microfuge tubes. Store at -20° 
C until use.
IEF Sample Buffer for Second Dimension SDS-PAGE
Tris base 0.15 g
SDS 0.4 g
2-Mercaptoethanol 1.0 ml
Glycerol 2.0 ml
H20 to 7 ml
Bromophenol Blue 0.02 g
H20 to 10 ml
Filter through a 0.22 pm syringe filter and aliquot. Store at -20° C until use.
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IEF Tube Gel Equilibration Buffer
Glycerol 5.0 ml
Dithiothreitol 65.0 mg
SDS 1.0 g
Bromophenol blue ~ 2 mg
Tris base 0.76 g
H.O 30 ml
6N HC1 to pH 6.8
H.O to 50 ml
Mix all ingredients until dissolved and store at 4° C until use.
IEF Tube Gels
Urea 1.9 g
Ampholytes (pi range 3-10) 58 pi
Ampholytes (pi range 5-7) 0.117 ml
30% Acrylamide, 5% C 0.365 ml
H ,0  1.13 ml
20% NP-40 0.35 ml
Mix all ingredients until dissolved, then add the following:
10% APS 25 pi
10% TEMED 25 pi
Swirl gently to mix and immediately pour into the tube gel caster per 
manufacturer's protocol.
LB Medium
Tryptone 10 g
Yeast Extract 5 g
NaCl 10 g
H ,0  to 1 L
For agar plates, add 15 g L 1. Heat to dissolve all components and autoclave for 
15 min at 250 psi.
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10X Phosphate Buffered Saline (PBS)
NaCl 30 g
KC1 a — ©
Na2HPO^ • 7H20 26.8 g
k h 2p o , 2.4 g
h 2o to 800 ml
HC1 to pH 7.4
h 2o to 1 L
SDS-PAGE Gel Solutions
Separating Gel Stacking Gel
40% Acrylamide (2.7% C) 3.3 ml 0.67 ml
1.5 M Tris, pH 8.8 2.5 ml **
0.25 M M Tris, pH 6.8 ** 1.25 ml
10% SDS 0.10 ml 0.05 ml
h 2o 4.0 ml 3.0 ml
10% APS 0.10 ml 0.05 ml
TEMED 4 pi 3 pl
Swirl to mix all ingredients and then add TEMED and APS. Make and cast the 
separating gel first and allow it to polymerize approx. 1 h. Then make and cast 
the stacking gel.
SDS-PAGE Running Buffer (Laemmli Buffer)
Glycine 14.4 g
Tris base 3.03 g
10% SDS solution (w/v) 10 ml
H20  to 800 ml
HC1 pH to 8.8
H20  to 1L
20X SSC
NaCl
Na3 citrate • 2H20  
H20  
1M HC1
h 2o
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STE
Tris-HCl
NaCl
EDTA
H;0
HC1 to pH 8.0
HzO
10X TBE Buffer
Tris base 108 g
Boric acid 55 g
0.5 M EDTA, pH 8.0 40 ml
H20  to 1 L
TE Buffer
1 M Tris, pH 8.0 10 ml
0.5 M EDTA, pH 8.0 2 ml
H20  to 1 L
Transblot Buffer
Glycine 43.2 g
Tris base 9.09 g
MeOH 600 ml
H20  to 3L
Tris-Buffered Saline containing Tween 20(TTBS)
Tris base 121.4 g
EDTA 8.18 g
NaCl 174 g
H20  to 15 L
HC1 pH to 8
Tween 20 20 ml
H20  to 20 L
Wash Buffer for Southern Blots
Low Stringency High Stringency
2X SSC 0.5X SSC
0.1%  SDS 0.1% SDS
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APPENDIX II
cDNA SEQUENCES
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T rout #10 cDNA sequences
10 week 0
AGGGCGAATTGGGCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGC  
AGAATTCGGCTTCCGGAGCGACCTGTACAGCCTCCGAGTTCACATTCAGTAGCTACTAC  
ATGGCTTGGATCAGACAGGCTCCGGGGAAAGGACTGGAGTGGACTGCTTCTAGTTATAG  
T AC TGC T AC ATATT ATTCCC AGTC AGTC C AGGGTAGA.TTC AC C ATCTC C A.G AGA.TGACT 
C C AGAAGT AAGCTGT AC CT AC AGATGAAC A.TTCTGAAG AGTGAAGAC AC CGCGCC  TTA.T 
T AC TGTC C GG ATCCGG AA.TTC C AGC AC ACTG
10 week 0
ATTGTATACGACTCACTATAGGGCGAATTGGGCCTCTAGATGCATGCTCGAGCGGCCGC
CAGTGTGATGGATATCTGCAGAATTCGGCTTCCGGAGCGACCTGTACAGCCTCCGAGTT
CACATTCAGTAGCTACTACATGGCTTGGATCAGACAGGCTCCGGGGAAAGGACTGGAGT
GGACTGCTTCTAGTTATAGTACTGCTACATATTATTCCCAGTCAGTCCAGGGTAGATTC
ACCATCTCCAGAGATGACTCCAGAAGTAAGCTGTACCTACAGATGAACATTCTGAAGAG
TGAAGACACCGCGCCTTATTACTGTCCGGATCCGGAATTCCAGCACACTG
10 week 10
TAATATGACTCACTATAGGGCGAATTGGGCCTCTAGATGCATGCTCGAGCGGCCGTAGT
GTGATGGATATCTGCAGAATCGGCTTCTGGTAGTTGTATCCTGTGTCATGGTAGATCCT
ACTCATACAGGCTGAGTAGTCAGGGGACTCCTGTAGGATCTCTCAAACTCACATGTGCC
TGTTGTGGATTACTCTAAGCAGCACTAATATGTTTGGATCGGCAGGCACCTGGAAAAGG
ACTTGAA
10 week 10
TATAGGGCGAATTGGGCCTCTAGATGCATGCTCGATCGGTCGCCAGTGTGATGGATATC
TGCAAATTCGGTTATATCTCCGCTCCGGAGCACATTGCGCAAGATGGAAAAAGTCGGAG
CAGTTGATGAGGCTGATGAAACAGTAACCATTGTCCCTTTCCCCCAGTAGTAAAAACGC
CGTGAGTAGCGAGCACAGTAATACACAGCTGTGTCTTCAGGTTGCAGGCTCATCCCTTG
TAAAGACACAGAGTTGCTGGAGGCATCTCTTGAAATGCTGAACTTGTTTTTCAATGCAT
CATTTTTG TATATG TCTCCATTATCCCATATA
10 week 10
GTAATACGACGCACTATAGGGCGAATTGGGCCTCTAGATGCATGCTCGAGCGGCCGCCA
GTGTGATGGATATCTGCAGAATTCGGCTTAGCTTCTGGGTTCACATTCAGTAGCTATGC
GATGAACTGGGTCAGACAGGCTCCTGGGAAAGGATTAGAGTGGATTGCTTATATCAGCA
CAGCTAGTACTCCCATATATTACTCCCAGTCAGTCCAGGGTAGATTCACCATCTCTAGA
GATGACTCCAGCAGTAAGCTGTACCTACAGATGAACAGTCTGAAGAGTGAAGACACAGC
GGTGTATTACTGTGCCGGTACGCGGGAGTGAATGCTTTTGACTACTGGGGGAAGGCACA
ATGGTTACCGTTTCATCAGCCTCATCAACTGCT
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10 week 10
GACGCACTATAGGGCGAATTGGGCCTCTAGTTGTATGCTCGATCTGTCGCTAGTGTGAT
GGATATCTGCAGAATTCGGCTTCTGTATCGCTTCTGGGTTCATATTCTGTAGCTATAGG
ATGGGTTGGATCAGACAGGCTCCTGGGATAGGACTGGAGTGGATTGCTTATATTAGCAC
ACAGAGTAATCCAATCTCTTATTCTCAGTTAGTCCAGGGTAGATTCACTATCTCCAGAG
ATGACTCTAGCAGTAAGCTGTACCTACAGATGAACAGTCTGAGGAGTGAGGACACAGCA
GTGTATTACTGTGCTAGAGAGAACTACGCGCGTGTTGACTACTGGGGGAGAGGGACAAT
GGTTACTGTTTCATCAGCCTCATCAACTGCTTCGACTTTGTTCTCTC
10 week 10
AGGGCGAATTGGGCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGC
AGAATTCGGCTTCCGGAGCGACCTGTACAGCCTCCGAGTTCACATTCAGTAGCTACTAC
ATGGCTTGGATCAGACAGGCTCCGGGGAAAGGACTGGAGTGGACTGCTTCTAGTTATAG
TACTGCTACATATTATTCCCAGTCAGTCCAGGGTAGATTCACCATCTCCAGAGATGACT
CCAGAAGTAAGCTGTACCTACAGATGAACATTCTGAAGAGTGAAGACACCGCGCCTTAT
TACTGTCCGGATCCGGAATTCCAGCACACTG
Additional "representative" sequences (does not include all sequences obtained 
during the study - additional sequences will be archived in GenBank).
1 week 0 (also replicated by other control fish at this time point)
ACCTGTACAGGCTCTGGGTTCACATTCAGTAGCTATGGGATGAACTGGATCAGACAGGC
TCCTGGGAAAGGATTGGAGTGGATTGCCTATAGTTATAGTACTACTACATATTACTCCC
AGTCATTTCAGGGTAGATTCACCATCTCCAGAGATGACTCCAGCAGTAAGCTATACCTA
CAGATGAACAGTCTGAGGAGTGAGGACACAGCAGTGTATTACTGTGCTAGA
1 week 5 (also replicated by other control fish at this time point)
ACCTGTACAGGCTCTGGGTTCACATTCAGTAGCTATGGGATGAACTGGATCAGACAGGC
TCCTGGGAAAGGATTGGAGTGGATTGCCTATAGTTATAGTACTACTACATATTACTCCC
AGTCATTTCAGGGTAGATTCACCATCTCCAGAGATGACTCCAGCAGTAAGCTATACCTA
CAGATGAACAGTCTGAGGAGTGAGGACACAGCAGTGTATTACTGTGCTAGA
6 week 0
TGGATATCTGCAGAATTCGGCTTTCTGAGCATCACCTGTAAGGTCTCATATTCAGTTAC
TAACACTTGGACAGCTTGGATCCGAAAGCCTGCAGGGAAAGAACTGGAGTGGGTTGGAA
ATGTATATTCTGGAGACACACGATACAAGGATTCACTGAAGAACAAGTTCAGCCTCTCA
GTAGACTCTAGCAGTAATACTGTGTTTTTAAAAGGGCAGAACCTTCAGACTGAAGACTC
AGCTGTGTATTATTGTGCCTAC
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8 week 0
AATTGTAATACGACTCACTATAGGGCGAATTGGGCCGCTGCTAGATGCATGCTCGAGCG
GCCGCCAGTGTGATGGATATCTGCAGAATTCGGCTTAGACCTGTACAGCCTCCGAGTTC
ATCAACTGGGAGCGGAGATATGATGAAAGCCGAATTCCAGCACACTGGCGGCCGTTACT
AGTGGATBCGAGCTCGGWACCAAGCTTGGCGTAATCATGGTC
10 week 0
TACACTACTATAGGCGAATTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGA
TGGATATCTGCAGAATTCGGCTTTCAGTGAAACTATCTTGCCAAGTCTCTGGCTATGTC
CTGACAGACTATGGCACAGGTTGGATACGACAGCAGCCAGGGAAAACACTGGAGTGGAT
TGGGATCATCTGGGGTGGTGGATCCATCAACTCTGGAGCCTCTTTTAAGAGCAGATTCA
CCATCTCCAGAGACAGTAGTAATGTACTGTACTTAGACATCAGCAGTCTGCAGGCTGAG
GACACAGCTGTGTATTATTGTGCAAAAACTGGAGGCGAGGGCAGGGCTTTTGACTACTG
GGGGAAAGGCACAATGGTTACCGTTTCATCAGCCTCATCAACTGCTCCGACTTTGTTCC
CTCTTGCGCAATGTGGCTCCGGGAGCGGAGATATGATGAAAGCCGAATTCCA.GCACACT
GGCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCGT
10 week 0
TCTCTCCTGTAAGGATCTGGGTATTCTTTAACCAGTACCAGCTACTGTACAGGTTGGGT
ACGACAGCCTGCAGGAAAAGCACTGGAGTGGGTTGGATACATGTGTGGCAGTGSTAACA
TATACTACAGTGATAAGCTGAAAAACAAATTCAGTATCTCCAGAGACACTTCCAGCAGC
ACAGTGACTTTTAACAGGACAGAGTCTGCAGACTGAAGACACAGCTGTGTATTATTGTG
CTCGACGACGACTCTACTTTGACTACTGGGGGAAAGGGACCATGGTGACCGTGTCCACA
GCCTCACTCAACTGCTCSACTTTGTTCCCTCTTGCGCAATGTGGCTCCGGGAGCGGAGA
TATGATGAAGCCGAATTCTCGCAGATATCCATCACACTGGCGGCCGCTCGAGCATGCAT
CTAYGAGGGCCCAA
10 week 0
GGCTCCTGGGAAAGCACTGCAGTGGATTGCTTATATTAGCACACAGAGTAATCCAATCT
CTTATTCCCAGTCAGTCCAGAGTAGATTCACTATCTCCAGAGATAACTCTAGCAGTAAG
CTGTACCTACAGATGAACAGTCTGAGGAGTGAGAACACAGCAGTATATTACTGTGCTAG
AGAGAACTACGCCCGTTTTGACTACTGGGGGAAAGAGACAATGGTTACTGTTTCATCAG
CCTCATCAACTGCTCCGACTTTGTTCCYTCTTGCGCAATGTCGCTCCGGGAGCGAGATA
TCTGAAAGCCGAATTCCAGCACACGGCTYCTTTACTAGTGATCCGAGCTC
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11 week 0
CGCCAAGCTTGGTACCGAGCTCGCATCCACTAGTAACGGCCGCCAGTGTGCTGGAATTC
GGCTTCCGGATCCGGACAGTAATAAGCTGCTGTGTCCTCACTCTTCAGACTGTTCATCT
GTAGGTGTAGCTTACTGCTGGAGTCATCTCTGGAGATGGTGAATCTACCCTGGACTGAC
TGAGAGTAAGAGATTGGACTACTATATATGCCAATATAAGCAACCCACTCCAGTCCTTT
CCCAGGAGCATCTCTGATCCAGCTCATCTCATATCTACTGAATGTGAACTCAGAGGCTG
TACAGGGCTCTCCGGAAGCCGAATTCTGCAGATATCCATCACACTGGCGGCCGCTCGAG
CATGCATCTAGAGGCCCAATTCGCCCTATAGTGAGTCGTATTACAA
15 week 0
ATTGTCATGTAAAATCTCTGGGTTTGATATGACAAACTATTACATGCACTGGATAAGAC
AGAAACCAGGCAAAGCTCTGGAGTGGATTGGGAGAATTAACTCTGGTTCAACAGATGCT
CCAGTCTACTCAGACTCCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAG
CACACAGTTCTTAGAGGCCAAGAGTCTGAGTTCAGAGGACTCTGCTGTTTATTATTGTG
CTCGAGAGAGGGAATGGGGTGGGGAGCGGAGATATGA
15 week 5
AAGGTGCGGTGTCCTCACTCTTCAGACTGTTCATCTGTAGGTACAGCTTACTGCTGGAG
TCATCTCTGGAGATGGTGAATCTACCCTGGACTGACAGGAGTAAGAGATTGGATTACTC
TGTGTGCTAATATAAGCAACCCACTCCAGTCCTTTCCCAGGTGCCTGTCTGATCCAACC
CATCCTATATATTCTGAATGTGAACTCGGAGGCTGTGCAGGTCTCTCCGGA
15 week 5
CGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCTCTAGATGCATGC
TCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCGGCTTATTGTCATGTAAAATC
TCTGGGTTTGATATGACAAACTATTACATGCACTGGATAAGACAGAAACCAGGCAAAGC
TCTGGAGTGGATTGGGAGAATTAACTCTGGTTCAACAGATGCTCCAGTCTACTCAGACT
CCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAGCACACAGTTCTTAGAG
GCCAAGAGTCTGAGTTCAGAGGACTCTGCTGTTTATTATTGTGCTCGAGAGAGGGAATG
GGGTGGGAGCGGAGATATGATGAAAGCCGAATTCCAGCACACTGGCGCCGTTACTAGTG
ATCCGAGCTCGTACCAAGCTTGCGTAAT
15 week 35
ATTGTCATGTAAAATCTCTGGGTTTGATATGACAAACTATTACATGCACTGGATAAGAC
AGAAACCAGGCAAAGCTCTGGAGTGGATTGGGAGAATTAACTCTGGTTCAACAGATGCT
CCAGTCTACTCAGACTCCCTGAAAGGCCAGTTCACCCTGACCGAGGACGTCTCTACAAG
CACACAGTTCTTAGAGGCCAAGAGTCTGAGTTCAGAGGACTCTGCTGTTTATTATTGTG
CTCGAGAGAGGGAATGGGGTGGGGAGCGGAGATATGATGAAAGCCGAATTCCAGCACAC
TGGCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCGTAATCATGGTCATA
GCTGTTTC
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* Kabat definition is based on sequence variability.
CDR1 - start is approximately residue 26.
Kabat definition starts 5 residues after CYS.
Residues before are always CYS-XXX-XXX-XXX-XXX.
Residue after always TRP. Typically TRP-VAL but may also be TRP-ELE,TRP-ALA. 
Length 10-12  a.a.
CDR2 - start is always 15 a.a. after the end of CDR1.
Residues before are typically LEU-GLU-TRP-ILE-GLY.
Residues after are LYS/ARG-LEU/ELE/VAL/THR/ALA-THR/SER/ILE/ALA.
Length 16 - 19 a.a.
CDR3 - start is always 33 a.a. after the end of CDR2 (always 2 residues after a CYS). 
Residues after are always TRP-GLY-XXX-GLY 
Length 3 - 2 5  a.a.
Antibody heavy chain CDR definitions per the mammalian model.
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VH Family
GenBank 
Accession # Reference
Onmy VH I M57442 1
X92501 2
S63348 4
L28741 5
X81490, X81484 7
Onmy VH II X65262 j
X81512, X81509 7
Onmy VH III L28742, L28805 5
X81509 7
Onmy VH IV L28744 5
Onmy VH V L28745 5
U04616, U04615 6
X81513, X81493, X81492, X81491 7
Onmy VH VI L28476 5
X81496,X81494,X81497, X81487 7
X81486,X81485. X81495.X81481 7
Onmy VH VII L28747 5
Onmy VH VIII X81501, X81503, X81499, X81488 7
X81498, X81482, X81502, X81500 7
X81483 7
Onmy VH IX X81505, X81504, X81507, X 81506 7
Onmy VH X X81508, X81489 7
Onmy VH XI X81511 7
Nomenclature of rainbow trout ig VH sequences as described in Roman et al. 1996. 
Sequences published in (1) Matsunaga et al. 1990; (2) Andersson et al. 1991; (3) Lee et al. 
1993; (4) Andersson and Matsunaga 1993; (5) Roman and Charlemagne 1994; (6) Hansen 
et al. 1995; (7) Andersson and Matsunaga 1995.
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R e p r e s e n t a t i v e  t r o u t  l g  V I I  f a m i l y  s e q u e n c e s  a r c h i v e d  in G e n B a n k  d a t a b a s e .
Fit I (JDK I FK2 CDR2 FK3
I  QT-LTESGPWK- ITGEPHKVTCTASGFTFS NYWMAWIRQAPGKGLEWIAHYKYDSAEI-YYSOSVQGRFTISRDNSKQQVYLQMNSLKTEDSAVYYCAR
I I  QWLTQTEQSVQGTPAGSLKLTCACSGFTLS STNMHWIRQAPGKGLEWIIYYYSDSDKSN- -APWQGRFTASKDSRN- -FYLHMSQLKPEDSAVYYCAR
I I I  QT-ELTQPGSLTLQPGQPLTLSCKVSGYSLT— STSYCTGWVRQPAGKALEWVGYMCGSGNI— YYSDKLKNKFSISRDTSSTTVTLTGQSLQTEDTWYYCAR
IV  DE-MDQSPSQVK-PRGDKFKLSCKISGFDMT NYYMHWIRQKPGKALEWIGVINSGSTDAPVY8DSLKGQFTLTEDVSTSTQFLEAKSLSSEDSAVYYCAR
V QT-LTESGPWK-KPGESH1CLTCTASGFTFS SYAMNWVRQAPGKGLEWIAYISTASTPI-YYSQSVQGRFTISRDDSSSKLYLQMNSLKSEDTAVYYCAR
lo VI E--ELTQPASMTVQSGQPLTISCKVS-YSVG--T--YYTAWIRQPAPKTLEWIGMKY-TGGT--HHKDSLKNKFSLTVDSSSNTVTLTGQSLQTEDTAVYYCAR
V II  GGLELSQPNVMWKPGESLSITCKVSGYSVSDSSISFATGWVRKPAGKAMEWISHIWDMGDI - -YKNDALKNKFSISTHASSNSVSLQGKSLQPEDTAVYYCAR
V I I I  QIVLTQASQP— GTPAGSLKLTCACSGFTLS RGNMFWIRQAFGKGLEWIIYYYSDSDKSN— APWQGRFTGSKDSSN--FYLHMSQLKPEDSAVYYCAR
IX QS-LTSSEPWK-RPSESVTLSCTVSGFSMGS YWMQWIRQKPGKGLEWIGFIDTGTT--AYYAQSLQGQFTITKDTSKNQLYLEMKSLRTEDSAVYYCAR
X D-IELIQSGPW IEPGVSFSISCKFSGFSIS SYCLGWIRQAEGKALEHVGVTCSSS-T— YTVDSLKSKITSRYDSSSSTVFLQGNNFQTEDTAVYYCAR
XI IS-LTSSPAQLK-PPGESVKLSCQVSGYALT SQGTGWIRQQPGKTLEWIGIIWSGGSIES--GASFKRRFTISRD-SSNVLYLDITSLQAEDTAVYYCAR
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Predicted SDS-PAGE banding patterns o f CNBr-digested trout heavy chains (Zhang 1999). The red bands 
represent the theoretical products generated by the CH portion. The blue bands represent the unique products 
o f VH digestion. The Roman numerals designate the VH families (I-XI) and the Arabic, distinct VH 
sequences within each family group. The sequence d a a  was obtained from GenBank.
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